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ABSTRACT
The gut-brain connection refers to the bidirectional communication pathway between the brain
and gastrointestinal (GI) system. Recent epidemiological research has suggested incidence rates
of Disorders of Gut Brain Interaction (DGBI) in emerging adults are increasing. The goal of the
study was to investigate the associations between the latent variables of GI health, psychological
distress, and impairment in general functioning (disability) across two time points. Although the
gut-brain connection has been established, research on its directionality and association with
functioning in emerging adults remains an understudied area. A repeated measures design was
used to collect data via an online survey in emerging adults (N = 861). Measurement equivalence
across time was established for each of the three latent variables. A cross-lagged panel model
(CLPM) was specified to explore reciprocal and directional influences. Three significant crosslagged paths were found. Higher levels of psychological distress at Time 1 predicted higher GI
symptoms at Time 2. This cross-lagged effect lends preliminary evidence gastrointestinal
symptoms may be a consequence of psychological distress in emerging adults. There was a
significant cross-lagged effect between GI symptoms at Time 1 and disability at Time 2. A
significant cross-lagged pathway from disability to distress was also found. The cross-lagged
design and significant cross-lagged paths offer stronger causal inferences than the traditional
cross-sectional design that is used to study the effects of GI symptoms. This study provides
psychometric evidence for the use of a latent construct of GI health using the PROMIS-GI®
subscales. Findings infer a directional pathway between the brain and the gut rather than a
bidirectional network. This signaling seems to be stronger from the brain to the gut than the gut
to the brain in emerging adults. Findings highlight the importance of the emerging field of
psychogastroenterology.
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CHAPTER ONE: INTRODUCTION
The gut and the brain are in continuous communication. Many are familiar with the
common sensation of “butterflies in the stomach” when experiencing anxiety or nerves.
Additionally, the popular statement referring to intuitive decision making “based on your gut or
having a gut feeling” also speaks to this relationship. The ongoing pathways between the brain
and the gut are referred to as the Gut-Brain connection. The Gut-Brain connection continues to
be a captivating area of psychological and gastroenterological research. Further understanding
the gut-brain axis (GBA) may yield recommendations for assessment and treatment of those with
gastrointestinal (GI) and psychological difficulties.

Biopsychosocial Model
The psychosocial complexity of self-reported gastrointestinal symptoms remains an area
of academic and clinical debate. The origins of this can be traced to the notion of dualism of the
human body. Dualism, or the notion of mind and body as separate entities, was accepted by
many until the rise of psychosomatic medicine. The premise of dualism was that the mind played
no role in biological and physiological processes. Psychosomatic medicine posited that
unconscious processes and psychological stress could manifest and be converted into physical
diseases, referred to at the time as hysteria (Gottlieb, 2003; Nimnuan et al., 2001). Many physical
illnesses once believed to have been caused by psychological states were disproven with medical
advancements. Nonetheless, the mind-body debate continued with the formation of the
biomedical model. The biomedical model focused on investigating for disease specificity within
the body. Subsequently, the role of psychosocial processes was viewed as secondary and
theorized would remit by treating the primary physical diagnosis. It was not until the late 1970’s
1

and early 1980’s that epidemiological studies revealed the importance of recognizing the mind
and body as important influences of one another. Specifically, acknowledging the role of
psychosocial factors, gastrointestinal symptoms, and illness behaviors. An investigation
comparing irritable bowel syndrome (IBS) patients seeking treatment to non-clinical IBS patients
in the 1980’s was one of the first to highlight psychosocial distress in relation to IBS. IBS is
characterized by abdominal pain and abnormalities in stool form and frequency (Mearin et al.,
2016). The researchers found higher levels of psychosocial distress enabled symptom severity
and illness behaviors. Higher levels of psychosocial distress led to increased healthcare seeking
and an increased prevalence of psychological disturbances in IBS patients vs. non-IBS patients
(Drossman, 1988; Tanaka et al., 2011; Whitehead et al., 1988).

Our understanding of the bidirectional relationship between the mind and body was
pioneered by George Ingel. George Ingel gave rise to the importance of understanding
psychological and social factors that are associated with and play an important role in physical
illness and diseases (Borrell-Carrió et al., 2004; Engel, 1977). The biopsychosocial model offers
an alternative framework to the dualistic notion of the mind and body. It gave rise to
considerations of psychological comorbidities, psychological states, and their influence on
physical conditions and self-reported physical experiences, such as pain. The biopsychosocial
model offers several advantages over the biomedical model. Research has shifted its perspective
to propose that illness is a byproduct of biological and psychosocial processes, and these
subsystems interact at multiple levels over time. Subsequently, these systems will then determine
the presence, severity, and duration of biological and aberrant somatic experiences.
Psychological research has evolved to encompass a multidisciplinary approach to illness. This
approach includes questionnaires to assess for broader psychosocial domains such as health2

related quality of life and coping. In addition, there is an initiative to capture patient’s
perceptions, behaviors, and include psychosocial assessments as standard of care in treatment
protocols. It is now crucial to include multivariate statistical methods to investigate and control
for interacting biopsychosocial variables in emerging research (Drossman & Hasler, 2016).
Neglecting the interaction of these variables may be a disservice to patients, the discipline, and
contributions to literature (Drossman & Hasler, 2016).

The Gut-Brain Connection
The bidirectional communication networks between the brain and the gut have been
studied extensively. The scientific breakthrough of the connection between the nervous system
and the digestive system is traced to the discovery of the enteric nervous system (ENS; (Mayer,
2011). The ENS governs the function of the gastrointestinal tract and processes food and waste.
It is estimated about 500 million neurons exist in the ENS, and these neurons communicate with
the central nervous system (CNS) through many neurotransmitters, including dopamine and
serotonin (Mayer, 2011; Mayer et al., 2015). The ENS and the CNS communicate and affect one
another through neural pathways including the vagus nerve, the immune system, and the
hypothalamic-pituitary-adrenal (HPA) axis (De Palma et al., 2014). As such, the combined
functioning of our GI system and the CNS activity is conceptualized under the GBA model or
gut-brain interaction (Foster & Neufeld, 2013). Within this framework, the gut is conceptualized
by many to be the “new brain.” Hence, the gut’s millions of neurons and bacteria (microbiome)
influence the brain’s health, and the brain’s functioning (i.e., anxiety, depression, or stress) can
influence the gut’s well-being. Interestingly, as much as 90 percent of the hormone serotonin
(responsible for mood regulation) can be found in our digestive tract (Yano et al., 2015). It has
3

been empirically established stress can affect both the gut bacteria and this vital communicative
system (De Palma et al., 2014; Mayer et al., 2015). In turn, the bidirectional pathways between
the gut and the brain can be affected, and may trigger self-reported discomfort, bloating, and gas
(Carabotti et al., 2015). The gastrointestinal (GI) system involves the brain, esophagus, stomach,
large intestine, small intestine, and the rectum. It is hypothesized in clinical patient populations
there might be a disturbance in this system. This could lead to a wide range of inflammatory and
functional GI disorders, obesity, or psychological complaints (Lucas, 2018; Mayer, 2011; Van
Oudenhove et al., 2016; Yukari et al., 2011).

Measuring the Gut-Brain Connection
There are several ways to assess gastrointestinal functioning. In patients with
inflammatory bowel diseases (IBD) such as Celiac Disease or Ulcerative Colitis, diagnosing
involves a gastroenterologist specialist. The diagnosis process may involve gastroenterological
examination, serology, phenotypic analysis, and endoscopic biopsy (Bai & Ciacci, 2017). To
assess for an individual’s self-appraisal of their gastrointestinal functioning as well as general
impact of symptoms on an individual’s functioning, another avenue is utilizing Patient Reported
Outcomes (PROs) via self-report measures. The National Institute of Health (NIH), in an
initiative to create PRO measures of physical, mental, and social health domains, developed the
Patient-Reported Outcomes Measurement Information System (PROMIS®;(Yount et al., 2019).
This system consists of freely available, brief, and psychometrically valid PRO measures. The
advantage of using PROs (i.e. self-report measures) is they can be easily implemented in
academic campus health centers or primary care facilities as a part of a needs assessment,
symptom management, outcomes assessment, and shared decision making (Yount et al., 2019).
4

Additionally, repeated measures can be more easily acquired to assess for change over time. One
study (Cassisi et al., 2020) illustrated that NIH PROs measurement systems could be easily
implemented into the workflow of a gastroenterology clinic. Another advantage of employing
self-report measures is they capture an individual’s appraisal of their own symptom presentation,
which will often be what they may verbally report to their physicians. Further, disorders of gutbrain interaction (DGBI) do not have direct biological correlates for a diagnosis, so symptom
classification using physiological tests would not be supported conceptually. This study does not
include direct measures of GI system activity through physiological tests. However, self-report
measures corresponding to these systems should correspond to GBA endpoints (Mayer et al.,
2015). Since there is a physiological and biological theoretical underpinning to this study, it is
plausible that stronger causal inferences can be made between GI health, psychological distress,
and disability with a cross-lagged panel model (CLPM).

5

CHAPTER TWO: LITERATURE REVIEW
Disorders of Gut-Brain Interaction (DGBI)
In a national GI survey, 61% of the community reported experiencing at least one GI
symptom per week and 58.4% of respondents reported co-occurring (i.e. two or more GI
symptoms) per week (Almario et al., 2018). Additionally, GI disturbances are some of the most
common and burdensome reasons for visits to primary and tertiary care offices, and digestive
diseases account for 100 million ambulatory care visits annually (Almario et al., 2018). The most
prevalent symptoms in clinical settings include heartburn/reflux (31%), abdominal pain (25%),
bloating (21%), diarrhea (20%), and constipation (20%) (Almario et al., 2018). As such, there
has been an increase in recognition of the brain-gut connection and the importance of addressing
the highly frequent comorbidities of anxiety, depression, and GI difficulties across many clinical
settings. For example, a previous study estimated 27% of female patients with irritable bowel
syndrome (IBS) have an anxiety disorder and 32% had a depressive disorder (Banerjee et al.,
2017). In addition, IBS patients frequently report high levels of caffeine, alcohol, nicotine use,
stress, depression, anxiety, and poor sleep habits (Canavan et al., 2014). Although IBS is not a
psychological disorder, psychological resources that help reduce chronic stress positively
influences IBS symptom experiences (Breit et al., 2018). The psychological mechanisms of
action may involve activation of the Parasympathetic Nervous System (PNS) through the vagus
nerve (Bonaz et al., 2018). Vagal tone is associated with the regulation of the stress response,
making it a possible modulator to help treatment of gastrointestinal and psychological disorders.
It is hypothesized the activation of the PNS through breathing techniques, meditation, and yoga
may help mitigate gastrointestinal symptoms (Breit et al., 2018). Attending to psychological and
6

quality of life (QOL) variables in those with clinical or non-clinical GI symptoms may have a
significant impact on symptoms and functioning. Since the empirical recognition of the GutBrain connection, there has been a new emerging field called psychogastroenterology (van
Tilburg, 2020). This field is devoted to addressing the complex gut-brain connection, to fill in
empirical gaps, and to provide clinical and empirical recommendations for clinical health
psychologists.
The discussion of IBS is an important one, because it was not until the formation of the
Rome Criteria that researchers and clinicians were able to fully classify on a symptom dimension
the experience of those with IBS. This was a breakthrough because until then, IBS patients were
a unique subset of gastroenterological patients. This was because their self-reported symptoms
did not have direct biological correlates, anatomical features, or a structural basis for diagnosis.
Up until 2016, these disorders were called Functional Gastrointestinal Disorders (FGIDs). The
term “functional” is now being phased out, and these group of disorders have been renamed as
disorders of gut-brain interaction or DGBI (Schmulson & Drossman, 2017). Utilizing the Rome
process to classify and legitimize the experience of IBS patients revolutionized our
conceptualization of symptom interpretation in psychogastroenterology. The rationale for a
symptom-based classification allowed for IBS to be diagnosed based off symptom groupings,
which are most often what patients are verbally reporting to their physicians. Since then, the
Rome process has evolved and received several iterations. Currently the field is on Rome IV.
The Rome IV criteria includes a diagnostic taxonomy containing 6 primary domains for adults.
These include 1.) esophageal disorders, 2.) gastroduodenal disorders, 3.) bowel disorders, 4.)
centrally mediated disorders of GI pain, 5.) gallbladder and sphincter of Oddi disorders, and 6.)
anorectal disorders. Each domain is classified based on the patient’s report of symptom type and
7

severity. The domain relevant to this study are 3.) bowel disorders (Lacy & Patel, 2017). Bowel
disorders are separated into 6 subcategories including an IBS subcategory, the most frequently
diagnosed GI disorder. Recently, applying the Rome IV criteria to DGBI has received some
criticism. Lacy et al. (2016) suggests that DGBI should be conceptualized as a “…spectrum of
chronic GI disorders with combinations of symptoms existing on a continuum rather than as
discrete disorders.” (Lacy et al., 2016) Additionally, neuro-gastroenterology has shifted to adhere
to a biopsychosocial model for their understanding of these disorders: “…without a structural
basis to explain its clinical features, our understanding of these disorders adhere to a
biopsychosocial model.” (Drossman & Hasler, 2016) Further research investigating the existence
of these disorders on a continuum is a necessary step for the progression of the field of
psychogastroenterology.

Abnormal GI Symptomatology
It is important to extend the discussion of classifying DGBI to include our understanding
of abnormal GI symptomatology. What is an abnormal GI experience? How do we better
understand and define not only specific symptoms that comprise our gastrointestinal functioning,
but what is the threshold for normality vs. abnormality? Could GI experiences be better captured
on a continuum?
DGBI are disorders defined by a combination of both “…chronic and recurrent
gastrointestinal symptoms that are not explained by structural or biochemical abnormalities.”
(Delvaux, 2003) The original conceptualization of DGBI viewed these disorders as
psychosomatic. Within this framework, psychological complaints and attention seeking behavior
were highly comorbid with GI symptoms. The most commonly reported GI symptoms included
8

excessive gas, bloating of the abdominal region, indigestion, and abdominal discomfort (Collins,
2007; Lea & Whorwell, 2004). Now, IBS and its symptom features are considered as
multifactorial, with psychological influences considered to be just one element of symptom
expression.
Since DGBI symptoms are non-specific and exist in the absence of any biomarkers, IBS
consists of a significant portion of these disorders. The etiology of IBS is unknown and is
accompanied by diarrhea, constipation (or alternating between both), and abdominal pain
(Collins, 2007; Delvaux, 2003). This syndrome can be episodic or continuous, and patients
report their symptoms persist over several years (Sperber et al., 2017). In the US, IBS affects 1015% of adults and account for 20-50% referrals to specialty gastroenterology clinics (Hulisz,
2004). Onset of IBS symptoms typically occur during adolescence years, and occur in those
between the ages of 15-65 (Quigley et al., 2016). Community based studies on IBS prevalence
reveal considerable heterogeneity across studies. In a recent epidemiological study, 41 countries
and 83 papers were investigating IBS prevalence across the globe. Results indicated a significant
degree of heterogeneity of IBS prevalence across the globe and a single pooled global prevalence
rate of IBS remains elusive. For example, some countries had a rate of 1.1% of IBS, where
others had 35.5% prevalence rate (Sperber et al., 2017).
Using the Rome IV classification system, IBS diagnostic criteria is defined as
experiencing recurrent abdominal pain on average at least 1 day per week in the last 3 months.
This abdominal pain must be associated with at least two or more of the following criteria 1.)
related to defecation, 2.) associated with a change in frequency of stool, and 3.) associated with
a change in the appearance of stool (Lacy & Patel, 2017). Other pain thresholds are set for
location of the pain, such as above the umbilicus area (i.e., the area around the bellybutton in the
9

abdomen). Pain thresholds and frequencies also differ on biological sex. In one of the largest
studies surveying 71,000 Americans, 65% of females endorsed experienced at least one GI
symptom in the past week, compared to 56.9% of males (Almario et al., 2018). This study also
found that those that are female, of younger age, are non-Hispanic white race/ethnicity, have a
higher educational level and other medical comorbidities are significantly more likely to
experience co-occurring GI symptoms (Almario et al., 2018). GI symptom prevalence
differences between men and women may be attributed to menses. Menses may increase the
likelihood that a female endorses belly pain, bloating/gas, nausea, or altered bowel habits (in the
form of diarrhea). An exploratory study found that experiencing one or more GI symptoms
before and during menses was very common in a healthy cohort of females (Bernstein et al.,
2014). In fact, 70% of their sample endorsed experiencing GI symptoms in conjunction with
their menstrual cycle (Bernstein et al., 2014).

Population: Emerging Adults
The time period between adolescence and full adulthood occurs between the age of 18
and 25. This crucial time period is termed emerging adulthood (Arnett, 2000). Emerging
adulthood can be marked by instability, social and geographical changes, a shift from
dependence to independence, and a change from pediatric to adult healthcare utilization.
Epidemiological research has established emerging adults are at an increased risk for a host of
psychological problems and transitional difficulties. These changes create uncertainty, which
place demands on the individual’s coping skills and may precipitate depressive episodes or lead
to an exacerbation of existing depressive symptomatology. Specifically, the National Institute of
Health (2016) indicates the prevalence of major depressive episodes is the highest, 10.9%,
10

among individuals in this period as compared with other age groups. According to Mojtabai et al.
(2016), between 2005 and 2014, 12-month major depressive episodes in young adults increased
from 8.8% to 9.6% (Mojtabai et al., 2016). Furthermore, the National Institute of Mental Health
(2017) and results of the National Comorbidity Study Replication (NCS-R) by Harvard Medical
School reported that anxiety disorder prevalence was 22.3% for individuals ages 18-29.
Additionally, those between the age of 18-25 experienced the highest prevalence rate for any
mental illness, as described by emotional, behavioral, or mental disorders (Kessler et al., 2005;
Mojtabai et al., 2016). Research has indicated pediatric patients with IBS that transition into
adult healthcare “… demonstrate disease-related complications, poor self-management,
worsening disease complications, and low adherence to medications.” (Trivedi & Keefer, 2015)
Emerging adults represent a unique subset of the population, as at first glance, they
appear to be a relatively physically healthy cohort. However, recent epidemiological research has
suggested that incidence rates of DGBI in emerging adults are on the rise. A recent study
(Almario et al., 2018) investigated 12,419 emerging adults and found reported GI symptoms
were prevalent. In the study, 54.6% of the sample endorsed one or more GI symptom in the past
week, as measured by the NIH GI-PROMIS® scales (Almario et al., 2018). Previous research
conducted in the Health Psychology Lab (Vivier et al., 2020) found in an emerging adult sample,
25.8% reported experiencing at least one moderately severe GI symptom, such as gas or bloating
or belly pain. Another Health Psychology Lab study found that 38.1% of an emerging adult
sample reported experiencing moderate to severe anxiety, 33% reported mild depressive
symptoms, and 21.2% reported experiencing moderate to severe depressive symptoms (Ross et
al., 2020). This cross-sectional study demonstrated gastrointestinal symptoms mediated the
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relationship between anxiety symptoms and health-related quality of life (HRQoL), and partially
mediated the relationship between depressive symptoms and HRQoL (Ross et al., 2020).
Gastrointestinal and psychological complaints have the potential of impacting multiple
domains of life. There has been an increase in academic and clinical work to acknowledge the
interplay of these variables. However, few studies have investigated these relationships specific
to the developmental period of emerging adulthood. As such, investigating an emerging adult
sample has several advantages over other subgroups of the population. As this cohort of the adult
population represents a non-clinical sample, it allows for testing theory-based hypotheses. This
research can also provide further evidence that incidence rates of DGBI are increasing in this
subset of the adult population.

Consideration of Relevant Issues of Diversity
The perception of a symptom may determine if it is viewed as an aberrant process,
illness, or an indicator of a disease. Factors that contribute to symptoms perceptions include the
population, cultural group, and values of an individual. For example, one population may
perceive a symptom as problematic, and another may not. Additional influences may include
societal and cultural values, individual temperament variances, and as noted previously,
biological sex. Indeed, cultural influences have been found to have an impact on symptom
presentation and healthcare seeking behavior in DGBI (Chuah & Mahadeva, 2018). One major
shift in Rome IV was addressing previous multicultural limitations by moving from a Western
ethnocentric focus to adapting a multicultural orientation. This orientation focuses on
conceptualizing DGBI and culture in relation to the patient, physician, food and eating, symptom
interpretation, and manifestation (Chuah & Mahadeva, 2018). Culture also strongly influences
12

illness explanatory models (Dinos et al., 2017). Illness explanatory models are symptoms or
disease related beliefs that affect concerns and expectations related to healthcare (Dinos et al.,
2017). Symptom reporting is an additional factor to consider, and this is especially apparent with
translation across different languages. Due to this, Rome II removed the term “discomfort” to
“pain” in Rome IV. Additionally, the term “bloating” poses issues in translatability (in Spanish
and Italian languages;(Schmulson & Drossman, 2017). Pictograms may need be designed and
validated in cross-cultural work. Additionally, effective and efficient recruitment of diverse
populations is lacking. The effects of socioeconomic status have not been well described in
previous studies.
Studies investigating cultural factors postulate that language, symptom perception and
cultural habits strongly influence disease presentation in Eastern cultures compared to Western
cultures (Francisconi et al., 2016). Studies also find that Eastern and Western cultures differ
greatly on occurrence of abdominal pain and bloating frequency in those with IBS. For example,
Hong Kong IBS studies report 32% of those with IBS report abdominal pain, and 68% report
bloating. Chinese based studies report 58% abdominal pain and 64% bloating in IBS patients,
compared to European studies that report 88% abdominal pain and 80% bloating rates. In the
United States, prevalence studies report 100% abdominal pain frequency in irritable bowel
studies and 83% bloating (Sperber et al., 2020). IBS appears to be more frequently reported in
females, those of younger ages, and non-Hispanic White race ethnicities (Almario et al., 2018;
Herman et al., 2010). Respondents that identify as Black and Asian are 31% and 35% less likely,
respectively, to have experienced GI symptoms within the past week compared to those that
identify as non-Hispanic White. Respondents that identify as Black, Asian, and Hispanic have
lower odds for reporting co-occurring symptoms. However, those that identify as Hispanic,
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Asian-American, Black, or Native American are more likely to endorse significantly impaired
HRQoL despite lower prevalence rates of IBS (Chuah & Mahadeva, 2018). Further, cultural
preferences for traditional remedies and variation in healthcare systems may lead to different
healthcare seeking behavior in Asian patients. It is unclear if these findings reflect lower
symptom burden or are attributed to cultural factors (Chuah & Mahadeva, 2018). Cultural status
also may influence verbal report in medical settings. For example, a patient of Asian descent
may be more likely to report physical symptoms rather than psychological symptoms (Chang et
al., 2006; Herman et al., 2010; Sperber et al., 2020; Sperber et al., 2017; Brennan MR Spiegel et
al., 2014).

GI Health: A Latent Construct
Prior to the formation of the Rome classification system, there was limited recognition or
understanding of symptoms or associated behaviors in the absence of pathology. The difficulty
of capturing prevalence rates of IBS and setting pain threshold criterion suggests an important
point; could symptom dimensions or groupings be better classified as one underlying construct
of GI health?
Recent cross-sectional evidence has suggested that an underlying construct of GI health
can be created using the NIH PROMIS® scales (Ross et al., 2020). The NIH PROMIS® includes
six symptom scales to assess for gastrointestinal functioning. Initially, a measurement model was
tested to create a higher-order construct of GI health using the PROMIS® GI symptom scales.
Latent GI health was estimated from the six symptom scales to assess for gas and bloating,
reflux, constipation, diarrhea, nausea and vomiting and belly pain (B. M. Spiegel et al., 2014).
The fit indices for the GI health measurement model indicated excellent fit: 2(9) = 67.91, p <
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.001, CFI = .96, RMSEA = .08, (90% CI .07, .10), SRMR = .03. This preliminary finding
supports the use of creating a higher-order construct of GI health using the six PROMIS® GI
symptom scales. The benefit of using a higher-order construct of GI health is to capture
individuals who may exhibit multiple GI symptoms across several symptom domains. This is
supported in recent research investigating the classification of GI symptoms in emerging adults
(Vivier et al., 2020). This study found that symptoms of bowel disorders occur on a continuum
of severity across fluctuating symptom areas. When applying a categorical approach, the mild
and moderate symptom groups fit most closely to IBS mixed or unclassified subtypes. Findings
concluded that this subset of the population do not fit neatly in a symptom classification and
supports a dimensional approach to assesses for gastrointestinal functioning. These findings
corroborated previous studies of DGBI (Chey et al., 2015; Lacy et al., 2016; Simren et al., 2017;
Whitehead et al., 2002).

Biopsychosocial Model and GI Health
The biopsychosocial model offers a framework for understanding the interconnected
relationship between biological functioning (i.e., GI health), social, and psychosocial processes.
Those with quality of life and psychological consequences due to their gastrointestinal symptoms
should not be viewed as less legitimate as those that carry a gastrointestinal diagnosis.
Gastrointestinal health has the potential to be an important avenue for general psychological
functioning and quality of life. Its associated features will be the topic of the next section.

Gut Brain Connection and Hypothesized Directionality
The directionality of psychological distress and GI symptoms is still relatively
undetermined. The biopsychosocial model and the gut-brain connection suggest psychological
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distress and GI symptoms are bidirectional in nature. Previous research has attempted to identify
the correct temporal order between psychological disorders and DGBI. That is, do psychological
symptoms precede having a GI condition? Or, in contrast, does a GI condition precede a
psychological condition? In a study investigating a community setting to examine these
associations, researchers found experiencing a simultaneous diagnosis of a GI and psychological
condition were observed in 5% of individuals, 61% of the sample experienced a psychological
condition that preceded their GI condition, and GI conditions were observed first in 34% of
individuals (Jones et al., 2017). Other prospective studies have elucidated in an estimated 50% of
IBS cases, gastrointestinal symptoms emerged first, followed by mood disorders (Koloski et al.,
2016; Koloski et al., 2012). Another study investigating incidence rates for mood, anxiety, and
IBS found 40% of mood disorders and 23% of anxiety disorders followed the onset of IBS
(Sykes et al., 2003). Other findings have suggested psychological distress may often precede GI
symptoms and a DGBI diagnosis (Jones et al., 2012). Other researchers have postulated the brain
drives IBS symptoms (conceptualizing IBS as a brain or somatic symptom disorder; (Patel et al.,
2015). Nonetheless, these findings are supportive of the bidirectional hypothesis suggested by
the biopsychosocial model (Jones et al., 2017). This research also supports the heterogeneous
nature of DGBI in terms of its reciprocal association with psychological symptoms.

Psychological Distress: A Risk Factor for Disorders of Gut-Brain Interaction
The gut-brain connection explains why stress and psychological factors are so closely
linked to gut function and dysfunction, gastrointestinal symptoms, illness, and disease
(Drossman, 2014). Social stressors have been shown to make DGBI refractory to treatment. Not
only are DGBI heterogeneous in presentation, but they are also strongly associated with mood,
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psychological conditions, and higher reported stress levels. Often, those in higher education are
undergoing higher levels of social, academic, and socioeconomic stressors. Previous research has
indicated IBS-like symptoms are highly prevalent in those enrolled in undergraduate and
graduate level education. In an international survey, 34% of undergraduate students, 41% of nonmedical graduate students, and 26% of medical graduate students endorse having IBS (Jafri et
al., 2005; Qureshi et al., 2016). Some researchers have even posited IBS symptoms are a global
challenge for those enrolled in university (Chen & Ye, 2020). Addressing psychosocial factors
are clinically significant, particularly in emerging adults (Chen & Ye, 2020; Lea & Whorwell,
2004).
Historically, stress has been a fascinating and complicated area of research across many
disciplines of psychology. Stress is an ambiguous construct and there is not one entirely agreed
upon definition. Humans are constantly changing organisms that function and adapt in
accordance with their environment. Any influence, adjustment, or adaptation on one’s
homeostasis can be considered a stressor (Selye, 2013). Stress can be biological, social, and be
perceived as desirable or undesirable. The most notable aspect of stress is a person’s
interpretation of the event. This interpretation of whether an individual perceives a stimulus or
life event as stressful can depend on a multitude of factors. This includes one’s coping
mechanisms, personality, culture, biology, attitudes, and previous experience with similar events
(Lazarus, 2006). Most healthy individuals that carry no GI diagnosis often experience abdominal
discomfort and changes in their bowels when they experience psychological distress. This
phenomenon underlies the observational relationship between GI function and an individual’s
psychological state (Drossman, 2014). Furthermore, psychological distress may play a pivotal
role in the homeostasis of the gastrointestinal systems. Some researchers consider IBS as a stress
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sensitive disorder (Qin et al., 2014). Previous research has indicated stress directly effects
intestinal motility (stretching and contracting within the GI tract), permeability (substances
passing through the intestinal wall), the gut microbiota composition, and visceral
hypersensitivity (decreased threshold for pain in the abdomen in response to pressure or
stimulation;(Chong et al., 2019; Zhou & Verne, 2011; Zhuang et al., 2017). It has been
postulated the mechanisms of action for stress on the GBA include the activation of the HPA
axis by the release of inflammatory cytokines, corticotrophin releasing factor (CRF),
adrenocorticotropic hormone, and cortisol (Chong et al., 2019; Dinan et al., 2006). In turn, these
effect the balance of the GBA and homeostasis of the gut. Clinically, there is an imperative to
teach patients with gastrointestinal complaints to manage levels of psychological distress as apart
of existing evidence-based therapies. The field devoted to these pursuits is called
psychogastroenterology (van Tilburg, 2020).

Psychological Distress: A Latent Construct
The multifaceted nature of one’s psychological health supports measuring an underlying
construct of psychological distress rather than depression and anxiety separately. This conclusion
is due to the inconsistent nature of self-report measures to reliability differentiate between the
two constructs of depression and anxiety in factor analytic studies. Although conceptually
depression and anxiety are distinct clinical psychological constructs, many commonly used
measures do not reliability distinguish symptoms and clinical features of these disorders. One
recent study proposed combining the Patient Health Questionnaire (PHQ-9) and Generalized
Anxiety Disorder Scale (GAD-7) scales in a bifactorial model as a composite measure of
Psychological distress (Teymoori et al., 2020). This study used confirmatory factor analysis
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(CFA) to create a bifactor model using a composite general distress factor with all 16 items from
both the PHQ-9 and GAD-7. The distress factor demonstrated good fit (χ2 = 96.1, p = .26,
CFI = .99; TLI = .99; RMSEA = .02). Additionally, the general distress measure accounted for
84% of the explained variance in the patient sample. Results indicated that by combining the
PHQ-9 and GAD-7 items, one can create a psychometrically valid latent construct of general
Psychological distress (Teymoori et al., 2020). This psychometric evidence also extends to other
self-report measures, such as the Hospital Anxiety and Depression Scale (HADS). A systematic
review of 50 latent variable analyses conducted on the HADS revealed it is unable to
consistently differentiate between the constructs of anxiety and depression. The review
recommends its use as a general measurement of distress (Cosco et al., 2012). Clinically, anxiety
and depression may share many of the same symptom features such as fatigue, difficulty
concentrating, irritability, and sleep disturbances. An ideographic review of individual test items
on these scales has clinical value. For example, on a depression scale, gathering information
related to suicidal or homicidal risk. Nonetheless, the nomothetic value of these scales remains to
be consistently supported empirically. As supported by previous factorial and latent structure
studies, this study used anxiety and depression measures as indicators of a higher-order latent
construct of psychological distress.

Disability Outcome: A Latent Construct
Gastrointestinal symptoms have the potential of incurring significant consequences on an
individual’s general functioning. Quality of life (QOL) or health-related quality of life (HRQoL)
is a multi-dimensional construct including physical, emotional, and social functioning as
measured by an individual’s self-appraisal of these domains. Disability and levels of functioning
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correlate highly with an individual’s HRQoL (Simões et al., 2016). Those that have impairments
in general functioning may have difficulty in the ability to fully engage in a social life, be
dependent on others, and experience diminished individual responsibility and fulfillment of
personal and social responsibilities. Self-report measures of disability and HRQoL are commonly
used in research as an outcome variable. Disability and HRQoL are commonly cited and
conceptualized as an outcome variable of the GBA. A self-report measure of disability quantifies
an individual’s objective performance in each life domain, whereas a measure of quality of life
(QOL) captures an individual’s subjective well-being (i.e. their satisfaction with a particular
health domain; (Üstün, Chatterji, et al., 2010). Ultimately, these constructs are interrelated. This
study focused on measuring disability and levels of functioning instead of QOL. This was
because disability is operationalized as an individual’s performance in multiple life domains
(such as self-care, communication, mobility, etc.). In contrast, quality of life is operationalized as
an individual’s satisfaction with their life domains. Additionally, there is a paucity of research
investigating disability in relation to gastrointestinal functioning. As such, most of the literature
found in the latter review reviewed HRQoL or QOL. A secondary aim of this study was to
further investigate the relationship between the construct of disability and gastrointestinal health
in emerging adults to fill this existing empirical gap.
In clinical populations, DGBI are associated with lower physical and mental HRQoL.
One study surveyed 6,312 participants with co-occurring multiple sclerosis and DGBI (Marrie et
al., 2019). Using the Rome III criteria, the prevalence of DGBI were statistically significantly
associated with increasing greater disability, and lower physical and mental HRQoL (Marrie et
al., 2019). In an internet-based survey, including US, Canada, and UK respondents, a study
utilized the Rome III criteria to investigate the population prevalence of DGBI and their
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cumulative effect on HRQoL outcomes (Aziz et al., 2017). 6,300 representative participants of
the general population were surveyed, and they found 35% of participants had a DGBI in
comparison to a non-GI diagnosis and organic GI-disease controls. Of note, the presence of
DGBI also had increasing somatic symptoms, worsening mental and physical QOL, and greater
healthcare utilization. Most interestingly was the finding that “…individuals with DGBI had
worse somatization and QOL scores than organic-GI disease controls.” (Aziz et al., 2017)
Further, DGBI represent the bulk of gastroenterology outpatient visits, and account for
12% of primary care visits. The burden of gastrointestinal symptoms on the healthcare system is
significant. IBS symptoms are associated with an estimated 2.2 million prescriptions and
estimated 8 billion of medical costs (Qureshi et al., 2016).
These findings, among others, suggest that there are significant unmet needs and burdens
placed on those with deleterious gastrointestinal functioning, such as their work productivity and
social functioning (Buono et al., 2017). The advantage of using a disability measure as an
outcome is its breadth of covering the multi-dimensional nature of functioning. These domains
may include difficulty understanding and communicating, getting around, self-care, getting along
with people, life activities (household and/or schoolwork), and participating in society. The
World Health Organization (WHO) originally created the WHO Disability Assessment Schedule
(DAS) to assess the functioning of psychiatric inpatients in 1988 using the International
Classification of Functioning, Disability, and Health (ICF) (Üstün, Kostanjsek, et al., 2010). The
ICF conceptualizes human functioning as a continuum of health states. ICF uses the
biopsychosocial model to conceptualize the varying degrees of functioning within each disability
domain. This model recognizes that disability is multidimensional, and to account for the
influence of social, environmental, and medical factors on functioning. Importantly, this
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classification postulates that everyone can exhibit some degree of disability at the following
levels: 1.) body (body functioning and structure), 2.) activities (activity limitations), and 3.)
participation (participation restrictions). Thus, they consider the body, the person, and the society
in their aim to capture the complete existence of disability (Üstün, Chatterji, et al., 2010). The
present study used this conceptualization and measurement for disability by using the WHODAS
2.0, a general health and disability measure. This measure includes six domains of functioning
that fall under the three levels mentioned above. These include self-care, cognition, mobility,
adaptive functioning, daily living, mobility, and communication (Federici et al., 2017; Üstün,
Kostanjsek, et al., 2010). The simple scoring approach of the WHODAS allows the sum of the
scores across all domains to represent a statistic to describe the degree of functional limitation in
the general population.

Current Study
Based on the existing scientific knowledge, the current study contributed to the growing
literature on the interplay of GI health, psychological distress, and disability over time using the
biopsychosocial framework. The goal of the study was to further understand the directional
relationships between these variables among an emerging adult population. Although the gutbrain interaction has been established, additional research on its directionality and its association
with functioning remain to be an understudied area in this population. This study had several
advantages over previous studies. Using a repeated-measures study design, data were collected in
two waves; at time one (T1) and time two (T2) with one month in between data collection (4weeks). This study design promoted a better understanding of temporal precedence and
predictive direction of testing three latent variables: GI health, psychological distress, and
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disability. Secondly, data collection was from a non-patient population. The advantage of a nonclinical sample supports analyses to investigate theory-based questions related to the gut-brain
connection. Using these measures, construct validity was established by providing evidence of
measurement equivalence, temporal stability, and predictive power. Error variance was
controlled for across the two time points.
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CHAPTER THREE: STUDY HYPOTHESES
The goal of this study was to test a biopsychosocial model of GI health, psychological
distress, and disability in an emerging adult population using a cross-lagged panel model
(CLPM). Cross-lagged associations between GI health, psychological distress, and disability
were examined. Using this methodology addressed the following study aims.

Study Aims
(1) Infer directional and reciprocal causation between GI health, psychological
distress, and disability using CLPM. The CLPM was examined for the strength of
the direct effects in the cross-lagged panel model. By choosing this method of
analysis, direction of these relationships and consideration of potential reciprocal
effects was conducted.
a. Consistent with the GBA hypothesis, it was hypothesized a reciprocal gutbrain connection would be established at T1 and T2. It was hypothesized
GI health would predict psychological distress and psychological distress
would predict GI health (bidirectionality/reciprocal cross-lagged effects).
(2) The CLPM analysis investigated the directional and reciprocal causation between
GI health, psychological distress, disability.
a. Does psychological distress and disability reciprocally interact over time?
b. Can a directional causation be inferred between GI health and disability at
T1 and T2? Does GI health predict disability over time?
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Gut-Brain Reciprocal Connection Hypotheses
It is well-established physical symptoms are strongly associated with psychological
distress. Gastrointestinal symptoms have emerged as one of the most dominant somatic symptom
clusters associated with distress (Patel et al., 2015; Qin et al., 2014; Simon et al., 1996; Spiegel
et al., 2008). In chronic GI disorders, clinical recommendations emphasize evaluating a patient to
determine “…whether patients are more gut than brain or more brain than gut in their illness
expression.” (Spiegel et al., 2011) This clinical concept is framed “GI distress.” (Spiegel et al.,
2011) Emerging adults are particularly vulnerable to stress and other psychosocial variables.
Higher psychological distress can lead to increased stress-response, inflammation, and arousal of
the autonomic nervous system (Koloski et al., 2016; Lucas, 2018; Mayer et al., 2015; Won &
Kim, 2016). These physiological mechanisms of action have the potential of leading to higher
self-reported gastrointestinal symptoms.

Hypothesis 1: GI health at Time 1 predicts psychological distress at Time 2.
Hypothesis 2: Psychological distress at Time 1 predicts greater GI Health at Time 2.
It was hypothesized these variables would both predict each other, i.e., they would
demonstrate a reciprocal and bidirectional relationship over time.

Psychological Distress and Disability Reciprocal Connection Hypothesis
Research has consistently demonstrated psychological distress and disability (defined as
impairments in functioning, difficulty engaging in activities of daily living, and general health)
are highly correlated. Individuals with disabilities often experience high rates of psychological
distress (Cree et al., 2020; Okoro et al., 2009). Additionally, major depression and anxiety
disorders lead to significant impairments in daily living and functioning. This is a requirement
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for a diagnosis of these disorders (Association, 2013). In a global population report published by
the World Health Organization, depression was found as the leading cause of disability
worldwide. The report found high rates of comorbid anxiety and depressive disorders (Friedrich,
2017). Additionally, the nature of anxiety and depression symptoms existing simultaneously
supports this study’s empirical reason for combining anxiety and depression measures into a
general measure of distress. Emerging adults also experience the highest prevalence rate for
emotional, behavioral, and psychological disorders (Kessler et al., 2005; Mojtabai et al., 2016).
According to the American College Health Association (2015), an estimated 60% of enrolled
college students self-report they experience overwhelming anxiety. The American College
Health Association also found 15% of emerging adults had depressive symptoms that they said
impacted their academic performance and ability to function (Blanco et al., 2008; Pedrelli et al.,
2015). Other college-based studies have revealed one-third of undergraduate students experience
suicidality, depression, or anxiety (Oswalt et al., 2020). Undergraduate students also exhibit high
comorbidity rates: of undergraduate students with depression, 40% also met diagnostic criteria
for generalized anxiety disorder (GAD) (Eisenberg et al., 2013; Oswalt et al., 2020). Guided by
these empirical findings, it was hypothesized there would be a reciprocal relationship between
these latent variables across the two time points.
Hypothesis 3: Psychological distress at Time 1 predicts disability at Time 2.
Hypothesis 4: Disability at Time 1 predicts psychological distress Time 2.
It was hypothesized these variables would both predict each other, i.e., they would
demonstrate a reciprocal and bidirectional relationship overtime.
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GI Health and Disability Outcome Hypothesis
Difficulty adjusting to life activities has been commonly reported in patients with DGBI.
GI symptoms are an illness burden that may affect an emerging adult’s working life and
academic functioning. IBS symptoms are associated with impaired work productivity, increased
healthcare utilization, more sick days, and other psychosocial domains (Faresjo et al., 2019).
Those with IBS indicate their GI symptoms significantly interfere with daily functioning, in that
they cannot fully engage with social, work, and home life. In one survey, respondents reported
GI symptoms impacted their productivity at an average of 8 days per month and missed an
estimated 1.5 days of work or school per month due to IBS (Ballou et al., 2019). Other data
suggest patients with IBS are twice as likely to take time off from work, exhibit high levels of
presenteeism (time at work unable to perform their best due to their illness), and demonstrate
impairment in daily activities (Corsetti & Whorwell, 2017). In one study, the impact of irritable
bowel syndrome – diarrhea (IBS-D) subtype on work productivity and engagement in daily
activities was investigated (Buono et al., 2017). Of 66,491 respondents in the U.S. based study
(participants aged 18 and over), those with IBS-D had significantly lower HRQoL, loss of work
productivity, daily living impairment, and had higher indirect costs associated with their health.
Based off these findings, it was hypothesized higher self-reported gastrointestinal symptoms
would lead to higher impairments in functioning (self-reported disability).
H5: GI health at Time 1 predicts disability outcome at Time 2.
It was hypothesized a unidirectional relationship between GI health and disability would
be established. It was hypothesized that inference of causality and temporal precedence could be
established between these latent variables at the two time points. This was an empirically derived
hypothesis as disability has been commonly cited as an outcome variable in connection with
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gastrointestinal disorders. Although the reciprocal relationship between mood (psychological
variables) and GI functioning has a theoretical and biological underpinning, disability is
conceptualized as an impairment in multiple life domains that often is a result of diminished
functioning related to physical or psychological disorders. In other words, disability as an
antecedent variable to GI symptoms does not have a theoretical basis. As such, a unidirectional
pathway was expected.

Contribution to Literature
As discussed in the literature review, the current evidence is mixed regarding the
temporal precedence of self-reported distress, gastrointestinal, and disability. Even more so,
these questions have not been investigated in an emerging adult sample. Studies have tried to
determine if GI conditions, or mood symptoms arrive first. Findings reveal high rates of
comorbidities (IBS patients present with high levels of anxiety and depression). Alternatively,
other studies have shown IBS symptoms are driven by the brain, suggesting mood
symptomatology arises first, preceding GI symptom presentation. The use of a non-clinical
sample has an advantage over clinical studies as it promotes an investigation of these theorybased questions. A cross-lagged panel models provides a methodological approach to examine
these reciprocal relationships over time. The presence or absence of reciprocal relationships
suggest a direction for assessment and intervention in individuals with these psychological and
physical symptoms. Notably, the emerging adult population are relatively understudied
particularly in this area of gastrointestinal health (Jafri et al., 2005; Qureshi et al., 2016). This
study addresses these gaps in the current literature.

28

CHAPTER FOUR: RESEARCH DESIGN AND METHODOLOGY
Participants
Eligibility Criteria
Participants met criteria to participate in the study if they were between the ages of 18
and 25 years (emerging adults) at the University of Central Florida. Participants were
undergraduates and enrolled in an introductory psychology course (General Psychology) and
participated in a two-part online study for course credit. Participants were across all
undergraduate majors at the university.

Recruitment
The online survey was presented on the university’s undergraduate psychology research
participation website with a brief description of the study’s components. Students were awarded
course credit for their participation. Participants were required to have taken the online survey at
Time 1 to take the survey at Time 2.

Ethical Concerns
The university’s Institutional Review Board determined the present study to be human
subjects research that is exempt from regulation (See Appendix A). The university’s Institutional
Review Board has also issued the study closure as data collection had been completed (see
Appendix B). Informed consent was obtained from all participants that took the study survey.
Data were all de-identified when downloaded as research personal only had access to a
Participant ID number. The participant ID is a randomly generated ID number that is assigned to
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research participants but has no connection to identifying information and there is no way to link
the ID with the student’s name. If a participant rated 1 (several days), 2 (more than half the
days), or 3 (nearly every day) on item 9 on the PHQ9 they were directed to services. Item 9 on
the PHQ9 asks: “Have you had thoughts that you would be better off dead or hurting yourself in
some way?” The following resources were provided to research participants: the number for
Counseling and Psychological Services (CAPS) at UCF, Crisis Hotline, and CAPS emergency
resources as well as their website URL.

Study Design and Procedures
Recall Period
The measures used here were available to use for research under the condition the
instructions would not be modified. The primary measures used in this study have a different
time window for participants to rate their functioning. In the case of the PROMIS measures,
recall is over the past 7 days. In the case of the GAD7 and PHQ9, it is a 14-day period. The
WHODAS requires a 30-day recall. The influence of recall period on self-report has been studied
empirically. Several studies have found no significant effects based on the length of recall
(Batterham et al., 2019; Condon et al., 2020; Lai et al., 2009). In one recent PROMIS study,
recall periods were compared across three conditions: no recall, 24- hours, or 7- days with the
PROMIS Physical Function Scale (Condon et al., 2020). According to the findings of the study,
the recall period did not have an effect on participant’s scores or responses (Condon et al., 2020).
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Study Design
Data were collected via an online survey over the course of five semesters at the
University of Central Florida. This study uses a repeated measures study design. A repeated
measures design refers to collecting multiple measures of the same variable taken on the same
subjects either under different conditions or over two or more time periods. Data were collected
at time one (T1) and time two (T2) with one month in between data collection (4-weeks). Data
collection began during the Spring 2019 semester. Within each semester, research participants
took part in a two-part survey. The online survey had a total of 140 questions and took
approximately 30 minutes to complete. The same online survey questions were repeated at each
time point. See Measures section for description of measures.

Study Setting
The study was conducted via an online format within the University of Central Florida’s
undergraduate research participation system. The website allows potential research participants
to peruse available online studies at the University of Central Florida. The website provides
participants with a brief description of the study and the amount of course credit they will receive
for participating. The undergraduate research participation system is synced with Qualtrics, an
online survey website for data collection. The research participant is then awarded course credit
once they complete the survey.
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Measures
Demographic Characteristics
Demographic characteristics included age, biological sex, racial or ethnic identification,
marital status, classification in college, housing, physiological profile including weight, height,
and smoking status. The survey also included a question if the research participant carries a
diagnosis of diabetes, IBS, Celiac Disease, or does not know. The survey contained an item for
female research participants to rate the degree to which any gastrointestinal symptoms they
reported are related to their menstrual cycle. This item is presented on a Likert scale of 0 (not at
all) to 4 (very much). Lastly, a medical services question inquired on a yes/no basis if the
participant had sought out medical treatment for their gastrointestinal health over the last six
months.

Validity Check Items
Nine items were dispersed randomly throughout the survey to identify participants that
had random, careless, or had inattentive responding. Example items include: “For this item,
please select Yes,” and “For this item, please select Never.” Participants were excluded from the
sample if they answered one or more of these questions incorrectly. This approach has been used
successfully in the Health Psychology laboratory. The use of VCheck items is recommended for
psychological assessment (Groth-Marnat & Wright, 2016).
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Psychological Distress
NIH PROMIS
The National Institute of Health has developed the Patient-Reported Outcomes
Measurement Information System (PROMIS). The PROMIS is a standardized set of patientreported outcomes that assess for multiple domains of health, including physical, psychological,
and social health. The PROMIS can be used in both clinical populations and in the general
population (B. Spiegel et al., 2014). All PROMIS measures in the present study were scored via
the Health Measures Scoring Service, powered by Assessment Center℠. As recommended by
the creators, T scores were used for analyses and interpretation. A T score is a standardized score
that is based on a normal curve where a T score equivalent to 50 is an average score of a
comparison or norm group.
NIH PROMIS Emotional Distress- Depression- Short Form 8a
This instrument is a fixed length short form that assesses for depressive symptoms
in the past 7 days. These items inquire about symptoms such as feeling worthless, helpless,
depressed, hopeless, like a failure, and unhappiness over the past seven days. The instrument
contains eight items on a 5-point Likert scale ranging from 1 (Never), to 5 (always). A T score
was used for analyses and interpretation. A T score is a standardized score that is based on a
normal curve where a T score equivalent to 50 is an average score of a comparison or norm
group. Reliability analysis was run (Cronbach’s alpha) for the NIH PROMIS Emotional
Distress-Depression. Acceptable internal consistency was found at both Time 1 (α = 0.95) and
Time 2 (α = 0.96).
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NIH PROMIS Emotional Distress-Anxiety Short Form – 8a.
The NIH PROMIS Anxiety-8a was designed as a fixed length short form to assess for
anxiety and fear in an adult population. This instrument contains eight items on a Likert scale
ranging from 1(Never) to 5 (Always). The eight items ask a respondent the degree they would
endorse symptoms such as feeling tense, anxious, nervous, uneasy, worried, fearful, and having
difficulty focusing. A T score was used for analyses and interpretation. A T score is a
standardized score that is based on a normal curve where a T score equivalent to 50 is an average
score of a comparison or norm group. Reliability analysis was run (Cronbach’s alpha) for the
NIH PROMIS Emotional Distress-Anxiety. Acceptable internal consistency was found at both
Time 1 (α = 0.96) and Time 2 (α = 0.97).

Patient Health Questionnaire 9 Scale
The Patient Health Questionnaire (PHQ-9) is a nine-item, self-report scale utilized to
screen for depressive symptoms over the past two weeks (Kroenke & Spitzer, 2002). Participants
rate each item on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The
PHQ-9 has demonstrated good internal consistency, test-retest reliability, criterion validity, and
construct validity across diverse racial ethnic groups, college populations, and primary care
studies in previous psychometric studies. Scores of 0-4 are considered minimal depressive
symptoms, scores of 5-9 are considered mild depressive symptoms, scores of 10-14 are
considered moderate depressive symptoms, scores of 15-19 are considered moderately severe
depressive symptoms, and scores of 20-27 are considered severe depressive symptoms
(Eisenberg et al., 2011; Huang et al., 2006; Kroenke & Spitzer, 2002). Reliability analysis was
run (Cronbach’s alpha) for the PHQ-9. Acceptable internal consistency was found at both Time 1
(α = 0.89) and Time 2 (α = 0.90).
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Generalized Anxiety Disorder 7 Scale
The GAD-7 scale is utilized to assess for cognitive symptoms of anxiety (Spitzer et al.,
2006). Each item asks participants to indicate the frequency with which they have experienced a
symptom during the past two weeks on a 4-point Likert scale ranging from 0 (not at all) to 3
(nearly every day). Research has indicated the internal consistency of the GAD-7 is excellent (α
= .92), and the test-retest reliability is good. Scores of 0-4 suggest minimal anxious symptoms,
scores of 5-9 suggest mild anxious symptoms, scores of 10-15 suggest moderate anxious
symptoms, and scores of 15-21 indicate severe anxious symptoms (Spitzer et al., 2006).
Reliability analysis was run (Cronbach’s alpha) for the GAD-7. Acceptable internal consistency
was found at both Time 1 (α = 0.93) and Time 2 (α = 0.93).
Higher-Order Psychological Distress Factor
A higher-order factor of psychological distress was created by using these four self-report
measures as indicators. Regarding the PHQ-9 and GAD-7, the summary scores were used as
indicators. T scores for the PROMIS measures were used as indicators. Taken together, these
four indicators (two anxiety measures, two depression measures) were used to create the higherorder latent construct of psychological distress. This was guided by several previous studies who
have created a latent construct labeled “distress” using indicators of both anxiety and depression
(Cosco et al., 2012; Teymoori et al., 2020; Wright et al., 2013). Although the chosen anxiety and
depression measures in this study have item content overlap, a visual inspection of these
measures show the PROMIS measures consistently inquire about cognitive symptoms, where
the PHQ9 and GAD7 also inquire about somatic symptoms. The additional anxiety and
depression measures allowed for a more comprehensive inclusion of both cognitive and somatic
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symptoms of these disorders. Additionally, the additional measures also allowed for a more
robust and reliable factor.

GI Health
PROMIS-GI
The PROMIS-GI  was developed to assess specific GI symptoms in six symptom
domains. These include gas and bloating, reflux, constipation, diarrhea, nausea and vomiting,
and belly pain separately (B. M. Spiegel et al., 2014). Research has indicated the symptom scales
demonstrate good construct validity in the general population and diverse gastrointestinal
patients. These symptom scales have been developed for both clinical practice and research (B.
M. R. Spiegel et al., 2014). As recommended by the creators of the PROMIS-GI , the present
study used the recommended T-scores for analyses (Broderick et al., 2013; Brennan MR Spiegel
et al., 2014). Reliability analysis was run (Cronbach’s alpha) for the PROMIS-GI . Acceptable
internal consistency was found at both Time 1 (α = 0.83) and Time 2 (α = 0.86). As supported in
previous work by the author, this study combined these six symptom scales into a general latent
construct titled GI health.

Disability and Functioning Outcome
World Health Organization Disability Assessment Schedule 2.0
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a 36item measure designed to assess for multiple domains of disability and functioning. Disability
was conceptualized as an outcome variable of the GBA. The WHODAS asks in the last month,
how often a participant has difficulty across six domains of functioning on a 5-point Likert scale.
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The Likert scale scores are assigned to each item as none (1), mild (2), moderate (3), severe (4),
and extreme (5). The six domains of functioning include: cognition (6 items), mobility (5 items),
self-care (4 items), getting along with people (5 items), life activities (8 items), and participating
in society (8 items). It is applicable in clinical, community, and general populations. The
WHODAS was designed to assess activity and participation restrictions, irrespective of a
medical diagnosis. Domain specific functioning scores were computed using the simple scoring
approach. This approach is done by summing the scores within each of the domain using the
scores assigned to each of the items: None is assigned a 1, Mild is assigned a 2, Moderate is
assigned a 3, Severe is assigned a 4, and Extreme or Cannot Do is assigned a 5. There is no
weighting of individual items. An overall summary functioning score is computed by summing
the six domain scores. This general disability score total is out of 180. The WHODAS manual
suggests the simple sum of the items across all domains represents a statistic adequate to
describe the degree of functional limitations. The DSM-5 recommends this scoring approach to
be used in busy clinical settings, such as student health services that may wish to replicate the
findings in this study. As such, it was appropriate to utilize the simple scoring approach for an
emerging adult population for this intended practical use. The psychometric properties
(unidimensionality) as well as the high internal consistency allows for simple sum of scores in
this way. Higher scores indicate a greater degree of disability. The WHODAS has been found to
be reliable and has a robust factor structure across cultures and different types of populations
(Üstün et al., 2001; Üstün, Kostanjsek, et al., 2010). Reliability analysis was run (Cronbach’s
alpha) for the WHODAS. Acceptable internal consistency was found at both Time 1 (α = 0.87)
and Time 2 (α = 0.86). The creators of WHODAS have published the WHODAS factor structure,
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confirming the six subdomains loading on a general disability factor. A general disability factor
was created by using the six domain subscale scores as indicators.

Statistical Analyses
Data Preparation
Data were accumulated across five academic semesters Spring - Summer (2019), Fall
(2019) -Spring (2020), and Summer (2020). All respondents who failed the VCheck items in
both Time 1 and Time 2 were removed. This was to eliminate respondents with inconsistent
responses. A deidentified participant ID was used to match those that completed the repeated
measures on Time 1 and Time 2. 142 participants completed Spring - Summer (2019), and 22
participants were removed for a N of 120 participants. 675 participants completed Fall 2019 Spring 2020 repeated measures, and 96 participants were removed for a N of 579 participants.
190 participants completed Summer 2020 repeated measures, and 28 participants were removed
for a N of 162 participants. The completed dataset was then combined across the five semesters
for a total N of 861.

Missing Data
Data were reviewed for missing data. A Qualtrics validation option was used to alert
respondents about questions they may have missed during the online survey. The type of
validation used in all questions in this study was called “forced response.” This option requires
the respondent to answer questions before they can continue the survey, preventing them from
going to the next page, and prompts them if their survey contains missing items. Thus, the
missing values in the data included the skip logic items in the PROMIS-GI ®. For example, if a
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respondent does not rate experiencing any GI symptoms in a symptom subscale, they will not be
shown the consecutive item and will be skipped to the next item in the following symptom
subscale. Thus, these items were recoded as system-missing (-999) in SPSS so that Mplus can
recognize these items (Muthén & Muthén, 2018).

Multivariate Normality
Prior to analyses, all variables of interest were examined using SPSS Version 26. Testing
the normality assumption in the sample was conducted by examining the skewness and kurtosis
coefficients. Recommendations for acceptable values of skewness and kurtosis values vary and
there is not one single statistic that captures all components of multivariate normality.
Considering this, recommendations from several sources were used (Kline, 2015; Looney, 1995;
Park & Schutz, 2005). For larger sample sizes (above 300) and for utilizing SEM methodology,
values between − 3 and + 3 are acceptable for skewness. Kurtosis values are deemed acceptable
if they are between the range of − 10 to + 10. However, some researchers recommend using -7
to +7 for kurtosis (Kim, 2013). As SEM is a robust analytical method and this study has a larger
sample size, small deviations may not represent major violations of assumptions. As such,
skewness values between -3 and +3 and kurtosis values between -10 and +10 were deemed
acceptable for the sample size (N = 861) and chosen statistical analysis (SEM).
The distribution for PROMIS-GI subscales were normal with acceptable skewness and
kurtosis values both at Time 1 and Time 2. Values ranged for the symptom subscales were (.05 1.5) for skewness and for kurtosis values ranged from (-.7 – 1.60). These values were deemed
acceptable and fell well within the acceptable skewness and kurtosis range suitable to conduct
SEM. Similarly, the psychological distress variables (PHQ9, GAD7, PROMIS Distress-Anxiety,
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and PROMIS Distress-Depression) were normal with acceptable skewness and kurtosis values
both at Time 1 and Time 2. Values ranged from (0.2 – 1.30) for skewness and for kurtosis
values ranged from (-0.4 – 1.60). Finally, the WHODAS subscales were also evaluated at Time 1
and Time 2. The distribution for the six WHODAS subscales scores were normal with
acceptable skewness (values ranging from .9- 2.50) and kurtosis values (0.5-6.99). It was
concluded that the variables reflected a distribution suitable for SEM analytic techniques.

Data Analysis Procedure
Descriptive Statistics
Descriptive statistics and demographic analyses were conducted using SPSS Version 26.
Structural equation modeling analyses were conducted using MPlus8 Version 1.6.
Structural Equation Modeling
This study utilized a cross-lagged panel model (CLPM). Panel models in SEM postulate
directional and regression relationships among repeated measures. A CLPM is a type of
structural equation model that is used where two or more variables are measured at two or more
occasions. This type of analysis is conducted when the study’s interest is on the associations
(often causal theories) with the variables over time. For example, a CLPM is often used when a
study is seeking to understand and infer the direction of causality. CLPM is suitable for a nonexperimental study where variables are recorded but not manipulated (Selig & Little, 2012).
Importantly, these statistical techniques are useful to infer causal predominance and to describe
reciprocal relationships between two or more variables (Kearney, 2017). “Crossed” refers to
estimating relationships from one variable to another, and “lagged” refers to the estimation of
these relationships across different time points (Time 1 and Time 2) (Hamaker et al., 2015). In
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addition, a CLPM can account for multiple-item indicators for each construct defined in the
model. This is accomplished by initially establishing measurement invariance over time. The
primary goal of this type of analysis is to understand how variables influence each other over
time and the directional influence variables may have on each other (Hamaker et al., 2015).
Measurement Invariance Across Time
Statistical analyses were conducted by specifying a latent variable cross-lagged panel
model in MPlus. The first step in conducting a CLPM is to test for measurement invariance of
our latent constructs. This CLPM was tested using the previously discussed latent constructs: GI
health, psychological distress and disability.
Testing for measurement invariance across time is important when using self-report
questionnaires for underlying psychological constructs in social sciences (Van de Schoot et al.,
2012). The goal for testing for measurement invariance across time was to ensure this study was
measuring identical constructs and the participants and underlying factors were being measured
similarly at Time 1 and Time 2.
Measurement invariance across time is achieved using increasingly constrained models
(SEM) and testing if there are significant differences between each model (Van de Schoot et al.,
2012). This was accomplished by specifying a CFA and then testing the increasingly constrained
set of models. First, a model was tested where factor loadings are equal across group, but
intercepts can differ (metric invariance). Second, a model was run where intercepts are held
equal, but factor loadings can differ (testing if intercepts are equal, i.e., intercept-only
invariance). Lastly, a model was run where both the factor loadings and the intercepts were
constrained to be equal (this tests for scalar invariance). Once this level of measurement
invariance held, CLPM was specified (Van de Schoot et al., 2012). As such, alternate fit indices
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were used to evaluate change in model fit after each constraint was placed on the nested models
(i.e. Model 1- Model 3; (Cheung & Rensvold, 2002). The fit indices used were RMSEA, TFI,
CFI, and SRMR (Cheung & Rensvold, 2002). The progress change in CFI (ΔCFI) was used as
an indicator of comparative fit for each model.
Cross-Lagged Panel Model
A CLPM was conducted in MPlus using maximum likelihood estimator with robust
standard errors. Four models (M1 – M4) were tested to investigate the relationship between the
three constructs of GI health, psychological distress, and disability. M1 and M4 are the most
meaningful models for interpretation as M1 tested for temporal stability and M4 included all
reciprocal and cross-lagged paths. However, M2 and M3 results were still included in the results
section.
Model 1 (M1) was an autoregressive model with no cross-lagged effects, also known as a
baseline or stability model. This model assumed the predictor of the variable at Time 1 is the
same variable at Time 2 and demonstrated temporal stability of the variables over time.
Model 2 (M2) was a model extending M1 that added cross-lagged paths from GI health at
Time 1 to psychological distress at Time 2, psychological distress at Time 1 to disability at Time
2, and GI health at Time 1 to disability at Time 2
Model 3 (M3) was a reverse model that added reverse cross-lagged paths to M1. These
reverse paths were: psychological distress at Time 1 to GI health at Time 2 and disability at Time
1 to psychological distress at Time 2. The path of GI health at Time 1 to disability at Time 2
remained in the model.
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Model 4 (M4) was a reciprocal causation model that included all autoregressive and
cross-lagged paths from M1 to M3 (Van de Schoot et al., 2012; Vötter & Schnell, 2019). See
Figure 1 below for the proposed CLPM that was conducted in this study.
Cross-lagged Panel Model Stability and Cross-lagged Effects
Finally, the previous models were examined for stability and cross-lagged effects.
Summary fit statistics are presented for the tested four models (M1 - M4). A cross-lagged effect
means that there is a significant effect of one variable on another variable after controlling for the
variable’s stability over time. The final model (M4) including all reciprocal pathways was
assessed for strength. Interpretation of Model 4 promoted a greater understanding of the latent
variable relationships that had the greatest and more significant predictors of reciprocal causality
over time (Juengst et al., 2017; Vötter & Schnell, 2019).
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GI health
Time 1

Psychological
distress
Time 1

Disability
Time 1

GI health
Time 2

Psychological
distress
Time 2

Disability
Time 2

Figure 1: Proposed Cross-lagged Panel Model.
Note. Two-wave cross-lagged panel model between GI health, psychological distress, and
disability. M1 Paths (orange lines) represent the baseline/stability model. M2 paths (black lines)
represent the normal causation model. M3-paths (blue lines) represent the reverse causation
model. All paths from M1 to M3 were included in M4, which was the reciprocal causation
model.
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CHAPTER FIVE: DESCRIPTIVE STATISTICS RESULTS
Sample Descriptive Statistics
See Tables 1- 14 for descriptive statistics. Overall, the emerging adult sample represented
a range of functioning in GI symptoms, psychological distress, and disability.

Pearson’s Correlation Coefficients
Pearson correlation coefficients were computed to assess the relationships between the
variables of interest at both time points. Results of the Pearson correlations indicated there were
associations of our indicators within the theorized latent constructs. Distress indicators (PHQ9,
GAD7, PROMIS-Distress Depression, PROMIS-Distress Anxiety) were moderately and
significantly correlated with one another. See Table 1 and 2. Conceptually, this supported the
creation of a higher-order factor of general psychological distress. PROMIS-GI subscales were
also moderately correlated with one another, and this trend was also seen with the WHODAS
domain subscales. This supports the use of data reduction techniques and the creation of latent
constructs as demonstrated in this study.

Age and Biological Sex
Participants were between the ages of 18-25 years old (N = 861). The sample consisted of
46.7% males (n = 402), 53.3% females (n = 459). Almost half of participants were 18 years old
(47.5%). 27.5% of participants reported being 19 years old and 11.6% reported they were 20
years old. Additionally, 5.9% of the sample were 21 years old and 2.6% of the sample were 22
years old, and 2.6% were 23 years old. Only 1.5% of the sample were 24 years old and 0.8% of
the sample were 25 years old. Then, an independent samples t-test was conducted to compare
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age and biological sex. There was no statistically significant difference in age between males
and females t(859) = 1.82, p > .05 in the sample.

Racial Ethnic Identification
The sample consisted of 0.35% American Indian/Native American (n = 3), 7.67%
Asian/Pacific Islander (n = 66), 8.59% Black (n = 74), 52.96% Caucasian (n = 456), 1.39%
Mexican American (n = 12), 4.88% Puerto Rican (n = 42), 14.17% Hispanic (n = 122), and
2.09% selected ‘other’ (n = 18). Of the respondents that selected “other,” respondents selfidentified with the following racial ethnic identities: Arab, Latina, East Indian, Ecuadorian,
Guyanese, Lebanese, North African, Brazilian, or Middle Eastern. Lastly, 68 respondents
identified with multiple racial ethnic identities (7.90%).

Smoking Status
123 participants (14.3% of the sample) endorsed smoking (including e-cigarettes and
vape pens), and 42 participants reported being an ex-smoker (4.9%). The majority of the sample
(N = 696, 80.80%) reported not smoking.

Marital Status
Participants were asked their marital status. Of the sample, only 4 participants reported
being married, and the overwhelming majority (99.5%) reported being unmarried.

Physical Health Diagnoses
Participants were asked if they had been diagnosed with any of the following: Diabetes,
IBS, Celiac Disease, none of the above, or if they did not know. Of the respondents, 7 identified
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they had been diagnosed with diabetes (n = 6 males, n = 1 female), 23 reported having IBS (n =
4 males, n = 19 females), and 7 reported having Celiac Disease (n = 2 males, n = 5 females). The
majority of participants (93.6%) reported not carrying any of the aforementioned physical
diagnoses (n = 806) and several reported not knowing (n = 18).

Classification in College
Participants were asked their classification in college (i.e., freshman/first-year,
sophomore, junior or senior). Over half of the sample (55.3%) reported being in their
freshman/first year of college (n = 476). Sophomore status consisted of 22.4% of the sample (n =
193), junior status consisted of 14.8% of the sample (n = 127), and seniors were only 7.5% of the
sample (n = 65).

Living Status
Participants were asked with whom they live with during their school year as well as
location. For options for whom they live with, the following choices were given living alone, one
or more other students, my spouse/partner, my child/children, parents, relatives, friends who are
not students, and other people. For location, the following options were given dormitory or other
campus housing, fraternity or sorority house, residence within driving distance, and residence
within walking distance. 3.3% of participants identified living alone (n = 28), 68.80% identified
living with one or more other students (n = 592), 2.9% reported living with a spouse or partner
(n = 25), 0.1% reported living with their child/children (n =1), 21.0% reported living with their
parents (n = 181), 2.2% of respondents reported living with other relatives (n = 19), 0.5%
reported living with friends who are not students (n = 4), and 1.3% reported living with other
people (n = 11). Regarding location, the sample was evenly split between living in a dormitory or
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other campus housing (45.1%, n = 388) compared to living in a residence within driving distance
(44.4%, n = 382). A small proportion of the participants reported living in a fraternity or sorority
house (0.8%, n = 7) and in a residence within walking distance (9.80%, n = 84).

Weight and BMI
Participants were asked how much they weigh as well as their height. The mean weight
across both sexes was 155.83 pounds (SD = 39.30). The mean weight for females was 141.26
pounds (SD = 30.59). The mean weight for males was 172.46 pounds (SD = 41.47). The mean
height across both sexes was 62.05 inches (5 feet and 2.05 inches). The mean height for females
was 60.00 inches (5 feet) and the mean height for males was 64.39 inches (5ft and 4.39 inches).
Then, Body Mass Indices (BMI) were calculated using participant’s reported height and weight.
The mean BMI across both sexes was 24.03 (SD = 4.93). The mean BMI for females was
23.71 (SD = 4.73). The mean BMI for males was 24.39 (SD = 5.14). A BMI of less than 18.5 is
considered underweight, a BMI between 18.5 to 25 is considered normal, and a BMI of 25 to 30
falls within the overweight range. If a BMI is 30 or higher, it falls within the obese range.
Then, an independent samples T-test was conducted to compare weight and biological
sex. There was a statistically significant difference in weight for females (M = 141.26, SD =
30.59) compared to males (M = 172.50, SD = 41.52); t(762.60) = 12.41, p < .05. These results
suggest weight does differ on biological sex in the sample, male participants reported higher
weight compared to females. This difference was statistically significant. Cohen’s d revealed that
there a small effect size for this difference (d = .29).
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Table 1: Correlation Table of Variables at Time 1
Variable
1
2
3
4
5
6
1 Belly Pain
1
2
.514**
1
Constipation
3 Diarrhea
.434** .514**
1
4
.541** .470** .401**
1
Gas/Bloating
5
.511** .367** .322** .424**
1
Nausea/Vomit
6 Reflux
.466** .481** .381** .472**
1
7 PHQ9
.404** .379** .302** .361** .470** .401**
8 GAD7
.429** .369** .319** .385** .473** .413**
9 PROMIS.346** .335** .264** .293** .406** .369**
Depression
10 PROMIS.444** .397** .343** .378** .488** .447**
Anxiety
11 Cognition .321** .254** .239** .249** .331** .274**
12 Mobility
.265** .220** .215** .160** .297** .238**
13 Self-Care .219** .189** .176** .082** .282** .195**
14 Getting
along with
.262** .250** .258** .184** .264** .256**
people
15 Life
.304** .288** .269** .232** .356** .330**
activities
16
Participating .321** .309** .286** .233** .362** .359**
in Society
17 WHODAS
Score
.356** .322** .306** .252** .396** .356**
Note. * Significant at the .01 level, ** significant at the .05 level

7

8

1
.744**

9

10

11

12

13

14

15

16

17

1

.733** .707**

1

.683** .840** .719**

1

.601** .515** .505** .501**
1
.366** .276** .277** .288** .567**
1
.399** .281** .340** .309** .509** .622**

1

.572** .478** .515** .466** .613** .446** .549**

1

.649** .539** .542** .520** .648** .511** .563** .627**

1

.611** .530** .506** .513** .622** .620** .613** .643** .661**

1

.688** .572** .578** .562** .827** .732** .735** .797** .867** .870** 1
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Table 2: Correlation Table of Variables at Time 2
Variable
1
2
3
4
5
6
1 Belly Pain 1
2
576** 1
Constipation
3 Diarrhea
.564** .563** 1
4
.569** .572** .466** 1
Gas/Bloating
5
.564** .486** .390** .494** 1
Nausea/Vomit
6 Reflux
.503** .525** .452** .536** .580** 1
7 PHQ9
.413** .444** .305** .382** .487** .417**
8 GAD7
.377** .400** .278** .355** .458** .378**
9 PROMIS.326** .364** .262** .314** .386** .359**
Depression
10 PROMIS.413** .460** .307** .389** .473** .408**
Anxiety
11 Cognition .321** .298** .224** .250** .324** .286**
12 Mobility
.264** .231** .253** .176** .322** .262**
13 Self-Care .211** .207** .207** .154** .257** .219**
14 Getting
along with
.251** .322** .290** .245** .261** .309**
people
15 Life
.335** .383** .308** .332** .401** .367**
activities
16
Participating .313** .343** .298** .250** .368** .330**
in Society
17 WHODAS
.365** .390** .334** .311** .415** .382**
Score
Note. * Significant at the .01 level, ** significant at the .05 level

7

8

9

10

11

12

13

14

15

16

17

1
.771** 1
.733** .706** 1
.744** .859** .730** 1
.629** .563** .526** .566** 1
.399** .347** .311** .328** .532** 1
.368** .336** .299** .316** .452** .630** 1
.580** .496** .487** .491** .575** .416** .493** 1
.653** .587** .533** .571** .611** .475** .536** .639** 1
.604** .561** .490

.545** .584** .561** .603** .652** .701

1

.706** .633** .579** .619** .804** .699** .708** .793** .870** .873** 1
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Table 3: Participant Demographics

Variables

N

%

459
402

53.30%
46.70%

3
66
74
456
12
42
122
18

0.35%
7.67%
8.59%
52.96%
1.39%
4.88%
14.17%
2.09%

68

7.90%

123

14.3%

696
42

80.80%
4.90%

7
23
7
806
18

0.80%
2.70%
0.80%
93.60%
2.10%

857
4

99.50%
0.50%

476
193
127
65
M
23.71
24.39

55.30%
22.40%
14.80%
7.50%
SD
4.73
5.14

Biological Sex
Female
Male
Racial Ethnic Status
American Indian/Native American
Asian/Pacific Islander
Black
Caucasian
Mexican
Puerto Rican
Hispanic
Other (Arab, Latina, East Indian, Ecuadorian, Guyanese,
Lebanese, North African, Brazilian, or Middle Eastern)
Identified with multiple racial ethnic identities
Smoking Status
Smoker (e-cigarettes and vape pens)
Non-Smoker
Ex-Smoker
Physical Health Diagnoses
Diabetes
Irritable Bowel Syndrome (IBS)
Celiac Disease
None
Reported not knowing
Marital Status
Single (never married)
Married/Living with Partner
Classification in College
Freshman/First Year
Sophomore
Junior
Senior
Body Mass Index (BMI)
Females
Males
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Table 4: PROMIS-GI T Scores Across Participants

Belly Pain
Constipation
Diarrhea
Gas/Bloating
Nausea/Vomiting
Reflux/Heartburn

Time 1
(N = 861)

Time 2
(N = 861)

M
33.90
36.60
39.90
36.70
40.60
31.20

M
43.76
44.03
44.24
48.62
46.97
43.00

SD
10.72
7.65
7.09
7.70
8.46
7.41

Time 1
Males
(n = 402)
SD
M
SD
10.74 40.72 8.99
7.98 42.49 6.92
6.78 43.47 5.89
8.39 45.96 7.26
8.10 44.83 6.39
7.43 42.07 6.88

Time 2
Males
(n = 402)
M
SD
43.19 9.74
44.94 7.03
44.22 6.38
47.29 6.92
46.46 7.05
43.26 6.87

Time 1
Females
(n = 459)
M
SD
48.88 10.84
47.32 7.99
45.63 7.61
53.23 7.27
50.74 9.07
44.95 7.77

Time 2
Females
(n = 459)
M
SD
46.42 11.43
45.38 8.59
44.92 7.41
50.95 8.63
48.85 8.93
43.82 7.79

Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored
as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. Symptom severity categories are mild (Tscores between 55 and 60), moderate (T-scores between 60 and 70), and severe (T-scores 70 and above).
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Table 5: PROMIS-GI Symptom Classification Across Participants (N = 861)
Time 1

Time 2

GI
Symptom
Severity

Belly
Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Belly
Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Within
Normal
Limits

493
(57.30%)

582
(67.60%)

617
(71.70%)

402
(46.70%)

536
(62.30%)

660
(76.70%)

565
(65.60%)

638 (74.10%)

667
(77.5%)

472
(54.80%)

605
(70.30%)

680
(79.00%)

Mild

261
(30.30%)

238
(27.60%)

203
(23.60%)

371
(43.10%)

208
(24.20%)

179
(20.80%)

219
(25.40%)

193
(22.40%)

161
(18.70%)

310
(36.00%)

174
(20.20%)

165
(19.20%)

Moderate

96
(11.10%)

39 (4.50%)

40
(4.60%)

86
(10.00%)

110
(12.80%)

22
(2.60%)

62
(7.20%)

25
(2.90%)

31
(3.6%)

76
(8.8%)

78
(9.10%)

16
(1.90%)

Severe

11
(1.30%)

1 (0.10%)

2 (0.20%)

7 (0.80%)

0

15
(1.70%)

5
(0.60%)

2
(0.20%)

3
(0.30%)

4
(0.50%)

0

Presenting
with
Symptoms

368
(42.74%)

244
(28.34%)

459
(53.31%)

325
(37.75%)

201
(23.34%)

296
(34.38%)

223
(25.90%)

194
(22.53%)

389
(45.18%)

256
(29.73%)

181
(21.02%)

2 (0.20%)

279
(32.40%)

Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored as Tscores. A T score is standardized with a mean of 50 and standard deviation of +/-10. T-scores were then converted into GI symptom
severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate (T-scores between 60 and 70), and
severe (T-scores 70 and above).
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Table 6: PROMIS-GI Symptom Classification for Males (n = 402)
Time 1

Time 2

GI
Symptom
Severity

Belly
Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Belly
Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Within
Normal
Limits

347
(86.31%)

366
(91.04%)

372
(92.53%)

329
(81.84%)

327
(81.34%)

381
(94.78%)

360
(89.55%)

381
(94.78%)

374
(93.03%)

340
(84.58%)

351
(87.31%)

383
(95.27%)

Mild

25
(6.20%)

27
(6.70%)

18
(4.50%)

56
(13.90%)

49
(12.20%)

16
(4.00%)

27
(6.70%)

16
(4.00%)

20
(5.00%)

48
(11.90%)

37
(9.20%)

16
(4.00%)

Moderate

28
(7.00%)

9
(2.20%)

12
(3.00%)

17
(4.20%

26
(6.50%)

5
(1.20%)

13
(3.20%)

5
(1.20%)

8
(2.00%)

14
(3.50%)

14
(3.50%)

3
(0.70%)

Severe

2
(0.50%)

0

0

0

0

2
(0.50%)

0

0

0

0

0

Presenting
with
Symptoms

55
(13.68%)

30
(7.46%)

73
(18.16%)

75
(18.66.%)

21
(5.22%)

42
(10.45%)

21
(5.22%)

28
(6.97%)

62
(15.42%)

51
(12.69%)

19
(4.73%)

0

36
(8.95%)

Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored
as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. T-scores were then converted into GI
symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate (T-scores between 60
and 70), and severe (T-scores 70 and above).

54

Table 7: PROMIS-GI Symptom Classification for Females (n = 459)
Time 1

Time 2

GI
Symptom
Severity

Belly
Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Belly
Pain

Constipation

Diarrhea

Gas/
Bloating

Nausea/
Vomiting

Reflux/
Heartburn

Within
Normal
Limits

325
(70.81%)

381
(83.01%)

391
(85.19%)

243
(52.94%)

194
(42.27%)

404
(88.02%)

356
(77.56%)

396
(86.27%)

398
(86.71%)

273
(59.48%)

324
(70.59%)

410
(89.32%)

Mild

57
(12.40%)

46
(10.00%)

39
(8.50%)

145
(31.60%)

74
(16.10%)

38
(8.30%)

41
(8.90%)

38
(8.30%)

36
(7.80%)

121
(26.40%)

67
(14.60%)

36
(7.80%)

Moderate

68
(14.80%)

30
(6.50%)

28
(6.10%)

69
(15.00%)

184
(18.30%)

17
(3.70%)

49
(10.70%)

20
(4.40%)

23
(5.00%)

62
(13.50%)

64
(13.90%)

13
(2.80%)

Severe

9
(2.00%)

2
(0.40%)

1
(0.20%)

2
(0.40%)

7
(1.50%)

0

13
(2.80%)

5
(1.10%)

2
(0.40%)

3
(0.70%)

4
(0.90%)

0

Presenting
with
Symptoms

134
(29.19%)

68
(14.81%)

216
(47.06%)

265
(57.73%)

61
(13.29%)

186
(40.52%)

135
(29.41%)

78
(16.99%)

55
(11.98%)

103
(22.44%)

63
(13.73%)

49
(10.68%)

Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are scored
as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. T-scores were then converted into GI
symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate (T-scores between 60
and 70), and severe (T-scores 70 and above).
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Table 8: Depression and Anxiety Scores Across Participants (N = 861)

M

SD

M

SD

Time 1
Males
(n = 402)
M
SD

PHQ-9

5.94

5.40

4.96

5.14

4.86

4.61

3.94

4.19

6.88

5.85

5.86

5.70

GAD-7

5.28

5.36

4.43

5.06

3.92

4.46

3.18

4.09

6.47

5.79

5.53

5.56

PROMISDepression

50.47

9.72

48.80

9.91

49.36

10.07

47.40

8.97

51.53

10.20

50.03

10.53

PROMISAnxiety

52.12

11.45

50.37

11.86

49.36

9.00

47.52

10.28

54.53

12.04

52.86

12.58

Time 1
(N = 861)

Time 2
(N = 861)

Time 2
Males
(n = 402)
M
SD

Time 1
Females
(n = 459)
M
SD

Time 2
Females
(n = 459)
M

SD

Note. The PHQ-9 summary scores were used (score ranges from 0 to 27). The GAD7 summary scores were used (score ranges from 0
to 21). The PROMIS-Emotional Distress measures are scored as T-scores. A T score is standardized with a mean of 50 and standard
deviation of +/-10.
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Table 9: Depression and Anxiety Symptom Classification Across Participants (N = 861)
Time 1

Time 2

Symptom Severity

PHQ-9

GAD-7

Within Normal
Limits/Minimal

425
(49.40%)
245
(28.50%)
124
(14.40%)
48
(5.60%)
19
(2.20%)

Mild
Moderate
Moderately Severe
Severe
Presenting with
Symptoms

436
(50.64%)

531
(61.70%)
177
(20.60%)
100
(11.60%)

PROMISDepression
409
(47.50%)
305
(35.40%)
131
(15.20%)

PROMISAnxiety
394
(45.80%)
230
(26.70%)
186
(21.60%)

*

*

*

53
(6.20%)

16
(1.90%)
452
(52.50%)

330
(38.33%)

PHQ-9

GAD-7
574
(66.70%)
169
(19.60%)
84
(9.80%)

PROMISDepression
488
(56.70%)
240
(27.90%)
117
(13.60%)

PROMISAnxiety
451
(52.40%)
207
(24.00%)
153
(17.80%)

51
(5.90%)

492
(57.10%)
223
(25.90%)
94
(10.90%)
35
(4.10%)
17
(2.00%)

*

*

*

34
(3.90%)

16
(1.90%)

50
(5.80%)

467
(54.24%)

369
(42.86%)

287
(33.33%)

373
(43.32%)

410
(47.62%)

Note. PHQ9 has symptom categories of minimal, mild, moderate, moderately severe. GAD7 has symptom categories of minimal,
mild, moderate, and severe. *PROMIS-Distress Depression and Anxiety measures provide categories of mild, moderate, and severe.
The PROMIS-Distress scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. Tscores were then converted into symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60),
moderate (T-scores between 60 and 70), and severe (T-scores 70 and above).
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Table 10: Depression and Anxiety Symptom Classification for Males (n = 402)
Time 1

Time 2

292
(72.60%)
66
(16.40%)
33
(8.20%)

PROMISDepression
292
(72.60%)
61
(15.20%)
46
(11.40%)

PROMISAnxiety
293
(72.90%)
33
(8.20%)
71
(17.70%)

*

*

*

11
(2.70%)

3
(0.70%)

110
(27.36%)

110
(27.40%)

Symptom Severity

PHQ-9

GAD-7

Within Normal Limits/
Minimal

227
(56.50%)
110
(27.40%)
49
(12.20%)
13
(3.20%)
3
(0.70%)
175
(43.53%)

Mild
Moderate
Moderately Severe
Severe
Presenting with
Symptoms

310
(77.10%)
65
(16.20%)
20
(5.00%)

PROMISDepression
307
(76.37%)
51
(12.70%)
42
(10.40%)

PROMISAnxiety
310
(77.10%)
34
(8.50%)
50
(12.40%)

*

*

*

7
(1.70%)

2
(0.50%)

8
(2.00%)

92
(22.89%)

95
(23.63%)

92
(22.90%)

PHQ-9

GAD-7

5
(1.20%)

255
(63.40%)
110
(27.40%)
26
(6.50%)
10
(2.50%)
1
(0.20%)

109
(27.11%)

147
(36.57%)

Note. PHQ9 has symptom categories of minimal, mild, moderate, moderately severe. GAD7 has symptom categories of minimal, mild,
moderate, and severe. *PROMIS-Distress Depression and Anxiety measures provide categories of mild, moderate, and severe. The
PROMIS-Distress scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. T-scores
were then converted into symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate
(T-scores between 60 and 70), and severe (T-scores 70 and above).
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Table 11: Depression and Anxiety Symptom Classification for Females (n = 459)
Time 1

Time 2

Symptom Severity

PHQ-9

GAD-7

PROMIS- PROMISDepression Anxiety

PHQ-9

GAD-7

PROMISDepression

PROMISAnxiety

Within Normal Limits /
Minimal

198
(43.10%)

239
(52.1%)

271
(59.00%)

231
(50.30%)

237
(51.60%)

264
(57.50%)

305
(66.40%)

268
(58.40%)

Mild

135
(29.40%)

111
(24.20%)

90
(19.60%)

67
(14.60%)

113
(24.60%)

104
(22.70%)

65
(14.20%)

46
(10.00%)

Moderate

75
(16.30%)

67
(14.60%)

85
(18.50%)

115
(25.10%)

68
(14.80%)

64
(13.90%)

75
(16.30%)

103
(22.40%)

Moderately Severe

35
(7.60%)

*

*

*

25
(5.40%)

*

*

*

Severe

16
(3.50%)

42
(9.20%)

13
(2.80%)

46
(10.00%)

16
(3.50%)

27
(5.90%)

14
(3.10%)

42
(9.20%)

Presenting with
261
220
188
228
222
195
154
191
Symptoms
(56.86%)
(47.93%)
(41.00%)
(49.70%) (48.37%)
(42.48%)
(33.60%)
(41.60%)
Note. PHQ9 has symptom categories of minimal, mild, moderate, moderately severe. GAD7 has symptom categories of minimal, mild,
moderate, and severe. *PROMIS-Distress Depression and Anxiety measures provide categories of mild, moderate, and severe. The
PROMIS-Distress scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10. T-scores
were then converted into symptom severity categorical levels using the suggested ranges of mild (T-scores between 55 and 60), moderate
(T-scores between 60 and 70), and severe (T-scores 70 and above).
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Table 12: DSM-5 WHODAS Symptom Severity Ranges for Participants (N = 861)
Time 1

Time 2

Within
Normal
Limits Mild

MildModerate

552
(64.1%)
749
(87%)

Self-Care

Disability
Symptom
Ranges

Within
Normal
Limits Mild

MildModerate

ModerateSevere

Severe –
Extreme

Presenting
with
Symptoms

231
(26.80%)
74
(8.60%)

72
(8.40%)
36
4.10%)

6
(0.6%)
2
(0.20%)

309
(36.00%)
112
(13.01%)

613
(71%)
769
(89%)

787
(91%)

44
(5%)

29
(3%)

1
(0.10%)

74
(8.59%)

Getting
Along with
People

630
(73%)

169
(20%)

54
(6%)

8
(1%)

Life
Activities

607
(70%)

180
(21%)

64
(7%)

Participating
in Society

710
(82%)

105
(12%)

General
Disability
Score

717
(83%)

118
(13%)

Cognition
Mobility

ModerateSevere

Severe –
Extreme

Presenting
with
Symptoms

162
(19%)
60
(7%)

78
(9%)
13
(3%)

8
(0.90%)
3
(0.30%)

248
(28.80%)
76
(8.83%)

803
(93%)

35
(4%)

19
(2%)

4
(0.40%)

58
(6.74%)

231
(26.83%)

686
(80%)

121
(14%)

49
(6%)

5
(0.5%)

175
(20.33%)

10
(1%)

254
(29.50%)

666
(77%)

138
(16%)

49
(5.7%)

8
(0.8%)

195
(22.65%)

41
(5%)

5
(0.50%)

151
(17.54%)

737
(85%)

84
(10%)

37
(4%)

3
(0.30%)

124
(14.40%)

25
(3%)

1
(0.1%)

144
(16.72%)

753
(87%)

86
(10%)

21
(2%)

1
(0.10%)

108
(12.54%)

DSM-5 recommends for interpretation to use average scores for each domain. These average scores are based on a 5-point scale which
allows the clinician to think of a participant’s disability within qualitative thresholds of (1) none, mild (2), moderate (3), severe (4), or
extreme (5). Average domain scores were calculated by dividing total sum score within each domain by the number of items. The
average general disability score was calculated by raw overall score by number of items in the entire measure (36). Scores were then
computed into severity ranges as follows: None-Mild disability was classified as 1 ≤ average score < 2, Mild-Moderate Disability
Severity Range was classified as 2 ≤ average score < 3, Moderate-Severe Disability was Disability as 3 ≤ average score < 4, and
Severe- Extreme Disability Severity Range was classified as 4 ≤ average score ≤ 5.
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Table 13: DSM-5 WHODAS Symptom Severity Ranges for Males (n = 402)
Time 1

Time 2

Within
Normal
Limits Mild

MildModerate

Cognition

272
(68%)

Mobility

Disability
Symptom
Ranges

Within
Normal
Limits Mild

MildModerate

ModerateSevere

Severe –
Extreme

Presenting
with
Symptoms

103
(26%)

25
(6%)

2
(0.5%)

130
(32.40%)

302
(75%)

359
(89%)

28
(7%)

14
(3%)

1
(.3%)

43
(10.70%)

Self-Care

372
(93%)

15
(4%)

14
(3%)

1
(.3%)

Getting Along
with People

295
(73%)

79
(20%)

27
(7%)

Life Activities

292
(73%)

85
(22%)

342
(85%)
345
(86%)

Participating
in Society
General
Disability
Score

ModerateSevere

Severe –
Extreme

Presenting
with
Symptoms

71
(18%)

28
(7%)

1
(.3%)

100
(24.88%)

368
(92%)

19
(5%)

15
(45)

0

34
(8.46%)

30
(7.46%)

375
(93%)

16
(4%)

9
(2%)

2
(.5%)

27
(6.72%)

1
(.3%)

107
(26.62%)

332
(80%)

57
(14%)

22
(5%)

1
(.3%)

80
(19.90%)

24
(6%)

1
(.3%)

110
(27.36%)

324
(81%)

62
(15%)

15
(4%)

1
(.3%)

78
(19.40%)

42
(12%)

16
(4%)

2
(.5%)

60
(14.93%)

355
(88%)

33
(8%)

13
(3%)

1
(.3%)

47
(11.69%)

48
(12%)

9
(2%)

0

57
(14.18%)

367
(91%)

26
(6%)

9
(2%)

0

35
(8.71%)

DSM-5 recommends for interpretation use only to use average scores for each domain. These average scores are based on a 5-point
scale which allows a clinician to think of a participant’s disability within qualitative thresholds of (1) none, mild (2), moderate (3),
severe (4), or extreme (5). Average domain scores were calculated by dividing total sum score within each domain by the number of
items. The average general disability score was calculated by raw overall score by number of items in the entire measure (36). Scores
were then computed into severity ranges as follows: None-Mild disability was classified as 1 ≤ average score < 2, Mild-Moderate
Disability Severity Range was classified as 2 ≤ average score < 3, Moderate-Severe Disability was Disability as 3 ≤ average score < 4,
and Severe- Extreme Disability Severity Range was classified as 4 ≤ average score ≤ 5.
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Table 14: DSM-5 WHODAS Symptom Severity Ranges for Females (n = 459)
Time 1

Time 2

Within
Normal
Limits Mild

MildModerate

280
(61%)
390
(85%)

Self-Care

Disability
Symptom
Ranges

Within
Normal
Limits Mild

MildModerate

ModerateSevere

Severe –
Extreme

Presenting
with
Symptoms

128
(28%)
46
(10%)

47
(10%)
22
(5%)

4
(0.9%)
1
(0.22%)

179
(39.00%)
69
(15.03%)

311
(68%)
401
(87%)

415
(90%)

29
(6%)

15
(3%)

0

44
(9.59%)

Getting
Along with
People

335
(73%)

90
(20%)

27
(6%)

7
(2%)

Life
Activities

315
(69%)

95
(21%)

40
(9%)

Participating
in Society

368
(80%)

63
(14%)

General
Disability
Score

372
(81%)

70
(15%)

Cognition
Mobility

ModerateSevere

Severe –
Extreme

Presenting
with
Symptoms

91
(20%)
41
(9%)

50
(11%)
14
(3%)

7
(2%)
3
(0.70%)

148
(32.4%)
58
(12.64%)

428
(93%)

19
(4%)

10
(2%)

2
(0.44%)

31
(6.75%)

124
(27.02%)

364
(79%)

64
(14%)

27
(6%)

4
(0.9%)

95
(20.70%)

9
(2%)

144
(31.37%)

342
(75%)

76
(17%)

34
(7%)

7
(2%)

117
(25.49%)

25
(5%)

3
(0.70%)

91
(19.83%)

382
(83%)

51
(11%)

24
(5%)

2
(0.44%)

77
(16.78%)

16
(3%)

1
(0.22%)

87
(18.95%)

386
(84%)

60
(13%)

12
(3%)

1
(0.22%)

73
(15.90%)

DSM-5 recommends for interpretation to use average scores for each domain. These average scores are based on a 5-point scale which
allows the clinician to think of a participant’s disability within qualitative thresholds of (1) none, mild (2), moderate (3), severe (4), or
extreme (5). Average domain scores were calculated by dividing total sum score within each domain by the number of items. The
average general disability score was calculated by raw overall score by number of items in the entire measure (36). Scores were then
computed into severity ranges as follows: None-Mild disability was classified as 1 ≤ average score < 2, Mild-Moderate Disability
Severity Range was classified as 2 ≤ average score < 3, Moderate-Severe Disability was Disability as 3 ≤ average score < 4, and
Severe- Extreme Disability Severity Range was classified as 4 ≤ average score ≤ 5.
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Gastrointestinal Symptoms and Menses
Female respondents (n = 459) were given the following item at both Time 1 and Time 2:
“Please rate the degree to which any gastrointestinal symptoms you reported are related to your
menstrual cycle.” This item was presented on a Likert scale of 1 (not at all), 2 (a little bit), 3
(somewhat), 4 (Quite a bit), or 5 (Very much). At Time 1 and Time 2, the modal response on this
item was 2.

Medical Treatment Sought for Gastrointestinal Health
All participants were asked if in the last six months they had sought medical treatment for
their gastrointestinal health. The majority (92.8%) of participants (n = 799) reported that they
had not, while a small proportion reported that they had (n = 62, 7.20%). Of those that reported
having Celiac disease (n = 7), 2 reported seeking out medical treatment for their gastrointestinal
health. In comparison, of those that reported having IBS (n = 23), 19 reported seeking out
medical treatment for their gastrointestinal health. Those with Diabetes (n = 7), 1 reported
seeking medical treatment for their gastrointestinal health.

Independent Samples T-Tests
Independent samples t-tests were conducted to determine if there were significant
differences between gastrointestinal health, psychological distress, and disability when
comparing males to females. The results of these tests can be found in Tables 15-17. These
findings revealed several of the symptom scales (GI health, psychological distress, and disability
subdomains) demonstrated significant differences (p < .05) on biological sex. These differences
may have been attributed to the large sample size (N = 861) which may increase chances of
63

finding statistically significant differences when such differences may be inconsequential in
nature. As such, effect sizes were reported to show the magnitude of the effect. A Cohen’s d =
0.2 is considered to be a small effect, d = 0.5 represents a medium effect, and d = .8 is considered
to be a large effect. In other words, if group means do not substantially differ by 0.02 standard
deviations these differences, although statistically significant, are negligible (Lakens, 2013).
Regarding gastrointestinal symptoms, an independent samples t-test was conducted to
compare group means for males vs. females on the PROMIS-GI symptom subscales (Table 10).
Females reported statistically significantly higher scores on the PROMIS-GI symptom subscales
compared to the males in the sample. Cohen’s d effect sizes revealed small effect sizes for these
differences in constipation, diarrhea, and reflux between males and females. Cohen’s d revealed
that there a medium effect size for these differences for belly pain (d = .55 at Time 1 and Time 2)
and nausea and vomiting (d = -.52 at Time 1, d = -.51 at Time 2) between males and females.
Lastly, Cohen’s d revealed a large effect size (d = -.84) for these differences in gas and bloating
at Time 1 between males and females and a medium effect size (d = -.62) at Time 2. See Table
15.
Regarding psychological distress, an independent samples t-test was conducted to
compare group means for males vs. females on the PHQ9, GAD7, PROMIS-Distress Depression,
and PROMIS-Distress Anxiety (see Table 11). Females reported statistically significantly higher
scores on the PHQ9, GAD7, PROMIS-Distress Depression, and PROMIS-Distress Anxiety than
males. Cohen’s d effect sizes revealed small effect sizes for these differences in the PROMISDistress Depression and PHQ9 measure at Time 1 and Time 2. Cohen’s d effect sizes revealed
there was a medium effect size difference for the GAD7 and the PROMIS-Distress Anxiety
measure at Time 1 and Time 2. See Table 16.
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Regarding disability and functioning levels, an independent samples t-test was conducted
to compare group means for males vs. females on the WHODAS-Disability domains subscales
and total score (Table 12). Males and females did not differ on the self-care and getting along
with people domain subscales at both Time 1 and Time 2. However, females reported
significantly higher scores on the disability scales of cognition, mobility, life activities,
participating in society, and in the general disability functioning total score at both Time 1 and
Time 2. However, Cohen’s d revealed small effect sizes for these differences. See Table 17.
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Table 15: Results of t-tests for Gastrointestinal Health by Biological Sex
Variables

Men vs Women at Time 1
95% CI for
t
df
Mean
Difference

Cohen’s d

Men vs Women at Time 2
95% CI for
t
df
Mean
Difference

Cohen’s d

PROMIS-GI
Belly Pain
-7.09, -4.31
-8.07**
859
-0.55
-7.09, -4.31
-8.05**
859
-0.55
Constipation
-3.38, -1.36
-4.61**
859
-0.32
-3.94, -1.84
-5.39**
859
-0.37
Diarrhea
-2.35, -0.46
-2.91**
859
-0.20
-2.35, -0.54
-3.13**
859
-0.21
Gas and Bloating
-6.90, -4.99
-12.25**
859
-0.84
-6.07, -3.92
-9.12**
859
-0.62
Nausea and
-5.38, -3.18
-7.65**
859
-0.52
-5.08, -2.97
-7.51**
859
-0.51
Vomiting
Reflux and
-2.68, -0.71
-3.37**
859
-0.23
-2.74, -0.76
-3.47**
859
-0.24
Heartburn
** p < .01
* p < .05
Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales were used. Symptom scales are
presented as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10
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Table 16: Results of t-tests for Psychological Distress by Biological Sex
Variables

Men vs Women at Time 1
95% CI for
t
df
Mean
Difference
-2.73, -1.31
-5.57**
859
-3.24, -1.85
-7.15**
859
-3.56, -0.97
-3.44**
859

Cohen’s d

Men vs Women at Time 2
95% CI for
t
df
Mean
Difference
-2.60, -1.25
-5.57**
859
-3.01, -1.69
-6.99**
859
-3.95, -1.32
-3.92**
859

Cohen’s d

PHQ-9
-0.38
-0.38
GAD-7
-0.49
-0.48
PROMIS-Distress-0.24
-0.27
Depression
PROMIS-Distress-6.67, -3.68
-6.79**
859
-0.46
-6.89, -3.79
-6.76**
859
-0.46
Anxiety
** p < .01
* p < .05
Note. The PHQ-9 summary scores were used. The PHQ-9 uses a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every
day). Scores range from 0-27. GAD7 summary scores were used. The GAD7 uses a 4-point Likert scale ranging from 0 (not at all) to
3 (nearly every day). Scores range from 0-21. Higher scores are indicative of greater depression and anxiety. The PROMIS-Distress
scales are scored as T-scores. A T score is standardized with a mean of 50 and standard deviation of +/-10.
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Table 17: Results of t-tests for Disability by Biological Sex
Variables

Men vs Women at Time 1
95% CI for
t
df
Mean
Difference

Cohen’s
d

Men vs Women at Time 2
95% CI for
t
Mean
Difference

df

Cohen’s d

WHODAS
Cognition (6 items)
-1.21, -0.06
-2.17*
859
-0.15
-1.44, -0.25
-2.77**
859
-0.19
Mobility (5 items)
-0.78, -0.02
-2.08*
859
-0.14
-0.81, -0.11
-2.54*
859
-0.17
Self-Care (4 items)
-0.46 –0.06
-1.50
859
-0.10
-0.35, 0.15
-0.78
859
-0.05
Getting Along with
-0.78, 0.17
-1.28
859
-0.09
-0.51, 0.40
-0.24
859
-0.02
People (5 items)
Life Activities (8
-1.66, -0.07
-2.14*
859
-0.15
-1.94, -0.45
-3.14**
859
-0.22
items)
Participating in
-1.56, -0.19
-2.51*
859
-0.17
-1.46, -0.15
-2.42*
859
-0.17
Society (8 items)
General Disability
-5.89, -0.68
-2.48*
859
-0.17
-5.94 -0.97
-2.73**
859
-0.19
Score
** p < .01
* p < .05
Note. WHODAS= World Health Organization Disability Assessment Schedule (WHODAS 2.0). The WHODAS domain specific
functioning scores were computed by summing the Likert scale scores within each of the domain. The Likert scale was on 1-5 scale.
The General Disability score is out of 180. Higher scores are reflective of greater disability.
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CHAPTER SIX: STRUCTURAL EQUATION MODELING RESULTS
Measurement Models
Initial confirmatory factor analyses (CFA) were conducted to evaluate the factor structure
of the latent constructs. Measurement models were conducted separately for each latent construct
at Time 1 and Time 2 (i.e., GI health, psychological distress, and disability) to evaluate
standardized factor loadings and overall model fit. The models were estimated with MPlus using
maximum likelihood estimation. For each CFA, correlated errors terms were allowed between
the same subscales at Time 1 and Time 2 (for example: belly pain at Time 1 and belly pain at
Time 2. All variables were treated as continuous. These results can be found in Tables 18-20.
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Table 18: Measurement Model of Gastrointestinal Health
PROMIS-GI T Scores at Time 1

Standardized Factor Loadings

Belly Pain

.739

Constipation

.696

Diarrhea

.603

Gas and Bloating

.693

Nausea and Vomiting

.637

Reflux and Heartburn

.686

PROMIS-GI T Scores at Time 2
Belly Pain

.777

Constipation

.759

Diarrhea

.673

Gas and Bloating

.739

Nausea and Vomiting

.690

Reflux and Heartburn

.704

Model Fit Indices
χ2 (df)

208.598 (47) *

RMSEA (90% CI)

.063 (.055, .072)

CFI

.974

TLI

.963

SRMR
.036
Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales
were used. RMSEA = root mean square of approximation; SRMR = standardized root mean
square residual; TLI = Tucker Lewis index; CFI = comparative fit index; df = degrees of
freedom; CI = confidence interval. Completely standardized solutions. *represents a significant
χ2 value with probability of .05. The error terms were allowed to correlate belly pain at Time 1
and belly pain at Time 2, constipation at Time 1 and constipation at Time 2, diarrhea at Time 1
and diarrhea at Time 2, gas and bloating at Time 1 and gas and bloating at Time 2, nausea and
vomiting at Time 1 and nausea and vomiting at Time 2, and reflux at Time 1 and reflux Time 2.
GI health factor at Time 1 could correlate with GI health factor at Time 2.
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Table 19: Measurement Model of Psychological Distress
Psychological distress at
Time 1

Standardized Factor
Loadings

PHQ9

.813

GAD7

.907

PROMIS-Distress Anxiety

.887

PROMIS-Distress Depression

.810

Psychological distress at
Time 2
PHQ9

.842

GAD7

.916

PROMIS-Distress Anxiety

.910

PROMIS-Distress Depression

.798

Model Fit Indices
χ2 (df)

131.320 (11) *

RMSEA (90% CI)

.113 (.096–.130)

CFI

.983

TLI

.958

SRMR
.023
Note. GAD7= Generalized Anxiety Disorder-7 Summary Score, PHQ9- Patient Health
Questionnaire -9 Summary Score, PROMIS Distress Anxiety T Score, & PROMIS Distress
Depression T Score RMSEA = root mean square of approximation; SRMR = standardized root
mean square residual; TLI = Tucker Lewis index; CFI = comparative fit index; df = degrees of
freedom; CI = confidence interval. Completely standardized solutions. *represents a significant
χ2 value with probability of .05. The error terms were allowed to correlate: PHQ9 summary score
at time 1 and PHQ9 summary score at time 2, GAD7 summary score at Time 1 and GAD7
summary score at Time 2, PROMIS-Distress Anxiety T score at Time 1 and PROMIS-Distress
Anxiety T score at Time 2, PROMIS Distress Depression T score at Time 1 and PROMIS
Distress-Depression T score at Time 2, PHQ9 summary score at Time 1 and PROMIS Distress
Depression T score at Time 1, PHQ9 summary score at Time 2 and PROMIS Distress
Depression T score at Time 2, GAD7 summary score at Time 1 and PROMIS Distress Anxiety
T score at Time 1, and GAD7 summary score at Time 2 and PROMIS Distress Anxiety T score
at Time 2.
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Table 20: Measurement Model of Disability
WHODAS at Time 1

Standardized Factor Loadings

Cognition

.757

Mobility

.718

Self-Care

.747

Getting Along with People

.764

Life Activities

.796

Participating in Society

.833

WHODAS at Time 2
Cognition

.708

Mobility

.678

Self-Care

.710

Getting Along with People

.755

Life Activities

.808

Participating in Society

.852

Model Fit Indices
χ2 (df)

364.834 (47) *

RMSEA (90% CI)

.089 (0.08–.097)

CFI

.958

TLI

.941

SRMR
.047
Note. WHODAS = World Health Organization Disability Assessment Schedule. RMSEA = root
mean square of approximation; SRMR = standardized root mean square residual; TLI = Tucker
Lewis index; CFI = comparative fit index; df = degrees of freedom; CI = confidence interval.
Completely standardized solutions. *represents a significant χ2 value with probability of .05. The
error terms for the following were allowed to correlate: cognition summary score at Time 1 with
cognition summary score at Time 2, mobility summary score at Time 1 with mobility summary
score at Time 2, self-care summary score at Time 1 and self-care summary score at Time 2,
getting along with people summary score at Time 1 and getting along with people summary
score at Time 2, life activities summary score at Time 1 and life activities summary score at
Time 2, and participating in society summary score at Time 1 and participating in society
summary score at Time 2.
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Testing Measurement Equivalence Across Time
Testing for measurement equivalence across time is done by performing sequential and
increasingly constrained confirmatory factor analyses (CFAs), where model constraints are
increasingly imposed on subsequent measurement models (Cadiz et al., 2009; Wang & Russell,
2005). Establishing measurement equivalence across time ensures assures comparisons made
between latent variable relationships are valid across time. The present study used the steps
outlined in (Vandenberg & Lance, 2000) as well as (Van de Schoot et al., 2012) for testing for
measurement equivalence. Sequential testing was done by conducting three separate models:
Model 1 (configural invariance), Model 2 (metric invariance), and Model 3 (scalar invariance).
Establishing measurement equivalence was performed on each of the study’s latent constructs
and the results will be presented separately (see Tables 21-23).
Studies have examined criterion to establish the strength and/or presence of measurement
equivalence across time (Cadiz et al., 2009; Van de Schoot et al., 2012; Vandenberg & Lance,
2000; Wang & Russell, 2005). In the current study, the chi-square test (χ 2) was not used as a
criterion for measurement equivalence. This was due to its sensitivity to sample size (Kline,
2015). As the present study has a large sample size (N = 861), the use of χ 2 test's may have
resulted in significant changes in fit where such changes could be inconsequential. As such,
alternate fit indices were used to evaluate change in model fit after each constraint was placed on
the nested models (i.e. Model 1- Model 3; (Cheung & Rensvold, 2002). The fit indices used were
RMSEA, TFI, CFI, and SRMR (Cheung & Rensvold, 2002). The progress change in CFI (ΔCFI)
was used as an indicator of comparative fit for each model. Multiple criteria for the cut-off value
for ΔCFI have been presented in previous research. A ΔCFI larger than .002 (Meade et al., 2008)
has been recommended as the most conservative indicator of non-equivalence as well as a cutoff
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of ΔCFI of no greater than .01 (Cheung & Rensvold, 2002). The present study used ΔCFI of no
greater than .01 to assess comparative fit across the models as well as evaluating the overlap of
the 90% confidence intervals of RMSEA. A |ΔRMSEA| value ≥ .015 is also evidence for noninvariance (Chen, 2007). χ 2 values will be presented in Tables 21-23 but were not used as
indicators for model fit of measurement equivalence. Measurement equivalence across time
results can be found in Tables 21-23

GI Health Latent Construct- Measurement Equivalence Model Results
Initially, configural invariance was tested, where no constraints are placed on the model
parameter estimates (i.e., allow factor loadings and item intercepts to vary). See Table 15 for
initial measurement model. See Table 21 for results of testing for measurement equivalence
across time. Results demonstrated acceptable fit for the configural invariance model (Model 1)
(RMSEA = .063; SRMR = .036; TLI = .963; CFI= .974).
The metric invariance model (Model 2) was tested by constraining factor loadings to be
equivalent. Subsequently, the configural model (Model 1) and metric invariance model (Model
2) were compared. The metric invariance model did not result in significantly worse fit (ΔCFI =
-.001), supporting weak measurement equivalence. Additionally, the RMSEA confidence
intervals overlapped (configural invariance 90% CI: .055 - .072, metric invariance 90% CI: .053.069).
The third model was the scalar model (Model 3), in which the first factor mean was
constrained to be zero to be able to estimate all the factor intercepts. The ΔCFI (-.003) met the
cutoff criteria for invariance (Cheung & Rensvold, 2002) and the RMSEA 90% CIs for the
metric and scalar models overlapped (metric invariance RMSEA 90% CI= .053 - .069; scalar
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invariance RMSEA 90% CI = .053 - .069. According to Chen (2007) a |ΔCFI| value ≥ .01 in
addition to a |ΔRMSEA| value ≥ .015 is evidence for non-invariance. The ΔCFI and ΔRMSEA
values did not meet these change criteria (Chen, 2007). Previous work has found that RMSEA
values can be inflated when models contain a larger number of items. This has been evaluated
with PROMIS measures and the degree to which they conform with the IRT assumption of
unidimensionality. This work has noted that the RMSEA index may not be an accurate indicator
of dimensionality of the large item banks of PROMIS measures (Amtmann et al., 2010; Cook et
al., 2009). Thus, it can be concluded the latent construct of gastrointestinal health using the six
PROMIS-GI six symptom subscales as indicators was measured similarly at Time 1 and Time 2.
Table 21: Measurement Equivalence Across Time Model for Gastrointestinal Health
Measurement
RMSEA
TLI
Equivalence
χ2
Δχ2
df
SRMR
CFI
ΔCFI
(90% CI)
(NNFI)
Model
PROMIS-GI
1. Configural 208.598 -47
.063 (.055,
.036
.963
.974
invariance
.072)
2. Metric
218.701 10.103 52
.061 (.053,
.044
.966
.973
-.001
invariance
.069)
3. Scalar
240.030 21.329 57
.061 (.053,
.050
.966
.970
-.003
invariance
.069)
Note. PROMIS-GI = National Institute of Health PROMIS-GI measure, all six symptom scales
were used. df= degrees of freedom; RMSEA = root mean square of approximation; CI =
confidence interval; TLI = Tucker Lewis index; NNFI = nonnormed fit index; CFI =
comparative fit index; SRMR = standardized root mean square residual; ΔCFI = change in CFI;
Δχ2 = change in χ2; ΔCFI < .002 and ΔCFI < .01 represents cut-offs for comparative fit.
*
represents a significant change in χ2 with probability of .05.
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Psychological Distress Latent Construct- Measurement Equivalence Model Results
Initially, configural invariance was tested where no constraints are placed on the model
parameter estimates (i.e., allow factor loadings and item intercepts to vary). See Table 19 for
initial measurement model. See Table 22 for results of testing for measurement equivalence
across time. Results demonstrated reasonable fit for the configural invariance model (Model 1)
(RMSEA = .113; SRMR = .023; TLI = .958; CFI = .983).
The metric invariance model (Model 2) was tested by constraining factor loadings to be
equivalent. Subsequently, the configural model (Model 1) and metric invariance model (Model
2) were compared. The metric invariance model did not result in significantly worse fit (ΔCFI =
-.001), supporting weak measurement equivalence. Additionally, the RMSEA confidence
intervals overlapped (configural invariance 90% CI: .096 - .130, metric invariance 90% CI: (.09 .121).
The third model was the scalar model (Model 3), in which the first factor mean was
constrained to zero to be able to estimate all the factor intercepts. The ΔCFI (-.001) met the
cutoff criteria for invariance (Cheung & Rensvold, 2002) and the RMSEA 90% CI’s for the
metric and scalar models overlapped (metric invariance RMSEA 90% CI= .090 - .121; scalar
invariance RMSEA 90% CI= .082 - .110). The comparison of Model 2 to Model 3 supports the
conclusion of strong measurement equivalence. According to Chen (2007) a |ΔCFI| value ≥ .01
in addition to a |ΔRMSEA| value ≥ .015 is evidence for non-invariance. The ΔCFI and ΔRMSEA
values did not meet these change criteria for non-invariance. Given that the RMSEA Confidence
Intervals did overlap, it can be concluded that measurement equivalence was met (Chen, 2007).
Results indicate the higher-order latent construct of psychological distress using the four
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measures (GAD7, PHQ9, NIH PROMIS Emotional Distress-Anxiety, NIH PROMIS
Emotional Distress- Depression) was measured similarly at Time 1 and Time 2.
Table 22: Measurement Equivalence Across Time Model for Psychological distress
Measurement
Equivalence
Model
1. Configural
invariance
2. Metric
invariance
3. Scalar
invariance

χ2

Δχ2

df

131.320 --

11

147.763 16.443

14

152.391 4.628

17

RMSEA
(90% CI)
.113 (.096,
.130)
.105 (.090,
.121)
.096 (.082,
.110)

SRMR

TLI
CFI
(NNFI)

.023

.958

.983

.033

.963

.982

-.001

.032

.969

.981

-.001

ΔCFI

Note. GAD7= Generalized Anxiety Disorder-7 Summary Score, PHQ9- Patient Health
Questionnaire -9 Summary Score, PROMIS Distress Anxiety T Score, & PROMIS Distress
Depression T Score were used to create a higher-order latent construct of Psychological
distress; df= degrees of freedom; RMSEA = root mean square of approximation; CI = confidence
interval; TLI = Tucker Lewis index; NNFI = nonnormed fit index; CFI = comparative fit index;
SRMR = standardized root mean square residual; ΔCFI = change in CFI; Δχ2 = change in χ2;
ΔCFI < .002 and ΔCFI < .01 represents cut-offs for comparative fit.
Disability Outcome Latent Construct- Measurement Equivalence Model Results
Initially, configural invariance was tested, where no constraints are placed on the model
parameter estimates (i.e., allow factor loadings and item intercepts to vary). See Table 20 for
initial measurement model. See Table 23 for results of testing for measurement equivalence
across time. Results demonstrated acceptable fit for Model 1 (configural invariance model)
(RMSEA = .089; SRMR = .047; TLI = .941; CFI = .958). These results indicate that the overall
latent factor structure of disability fits well for the study sample.
The metric invariance model (Model 2) was tested by constraining factor loadings to be
equivalent. Subsequently, the configural model (Model 1) and metric invariance model (Model
2) were compared. The metric invariance model did not result in significantly worse fit (ΔCFI =
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-0.000). Additionally, the RMSEA confidence intervals overlapped (configural invariance 90%
CI: .08, .097; metric invariance 90% CI: .076, .093).
The third model was the scalar model (Model 3), in which the first factor mean was
constrained to zero to be able to estimate all the factor intercepts. The ΔCFI (-.000) met the
cutoff criteria for invariance (Cheung & Rensvold, 2002) and the RMSEA 90% CI’s for the
metric and scalar models overlapped (metric invariance RMSEA 90% CI= .076, .093; scalar
invariance RMSEA 90% CI= .073, .089). According to Chen (2007) a |ΔCFI| value ≥ 0.01 in
addition to a |ΔRMSEA| value ≥ .015 is evidence for non-invariance. The ΔCFI and ΔRMSEA
values did not meet these change criteria for non-invariance. Given that the RMSEA confidence
intervals did overlap, it can be concluded that measurement equivalence was met (Chen, 2007).
Results indicate the measurement of the latent construct of Disability using the six WHODAS
subscales was measured similarly at Time 1 and Time 2.
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Table 23: Measurement Equivalence Across Time Model for Disability
Measurement
Equivalence
Model
1. Configural
invariance
2. Metric
invariance
3. Scalar
invariance

χ2

Δχ2

df

364.834 --

47

371.330 6.496

52

376.641 5.311

57

RMSEA
(90% CI)
.089 (.08,
.097)
.084 (.076,
.093)
.081 (.073,
.089)

SRMR

TLI
CFI
(NNFI)

.047

.941

.958

.049

.946

.958

-.000

.049

.951

.958

-.000

ΔCFI

Note. WHODAS = World Health Organization Disability Assessment Schedule, the six scales were used to create a
higher-order latent construct of Disability; df= degrees of freedom; RMSEA = root mean square of approximation;
CI = confidence interval; TLI = Tucker Lewis index; NNFI = nonnormed fit index; CFI = comparative fit index;
SRMR = standardized root mean square residual; ΔCFI = change in CFI; Δχ 2 = change in χ2; ΔCFI < .002 and ΔCFI
< .01 represents cut-offs for comparative fit.

Cross-Lagged Panel Model
Correlated Errors
A cross-lagged panel SEM was then specified to assess for temporal relationships
between gastrointestinal health, psychological distress, and disability. Modification indices were
examined, and correlated error terms were iteratively freed. Freeing correlated errors were
theory-driven rather than data-driven. For example, given that measurement was conducted on
two occasions, Time 1 and Time 2, it was not surprising correlated residuals of the repeated
measures were found across time. Researchers administering repeated measures in longitudinal
design is common, therefore it is expected the indicator residuals (IRs) of these measures would
correlate across time (Landis et al., 2009). The freeing of these correlations is less problematic as
they would be of cross-sectional data, as the “…residual variance can be portioned into random
and systematic error.” (Landis et al., 2009) Guided by these empirical recommendations,
correlations were allowed between the same measures at Time 1 and Time 2 as they had identical
content. For example, scores on the PHQ9 at Time 1 could correlate with scores at Time 2.
Additionally, latent variables at Time 1 were allowed to correlate with their respective latent
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variable counterpart at Time 2 (GI health at Time 1 was allowed to correlate with GI health at
Time 2). Two additional errors were allowed to correlate: psychological distress correlating with
Mobility WHODAS subscale and PHQ9 (depression measure) predicting disability. Research
has shown a strong relationship between depression (psychological distress) and physical
disabilities. More specifically, physical disability is operationally defined as experiencing
impairment in activities in daily living (ADL) and in mobility. A seminal longitudinal study
investigated a cohort of non-disabled subjects (N = 6247) and found depressed individuals at
baseline were more likely to be less physically active compared to non-depressed individuals. At
a 6 year follow up, depressed individuals were significant more likely to have impairment in
ADL and in mobility disability (Penninx et al., 1999). Additionally, depression has been cited as
the leading cause of disability around the world by the World Health Organization (BehrensWittenberg & Wedegaertner, 2020). Depression has been associated with significant disability
and burden across physical diagnoses (Behrens-Wittenberg & Wedegaertner, 2020; Ericsson et
al., 2002; Reddy, 2010). A correlated error implies residuals (error terms) are correlated with
variables in the model and with each other which implies a non-directional relation whereas a
unidirectional path implies causality. As these correlated errors have theoretical basis, they were
allowed to correlate. Additional correlated error terms may have significantly decreased χ2,
however, these lacked theoretical basis.

Biological Sex Covariate
Due to the ubiquitous significant differences in biological sex found across the measures
(see results of independent t-tests for reference), biological sex was added as a covariate to all
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cross-lagged paths. This covariate was included to control for the variance associated with
biological sex.

Model 1: Autoregressive Paths
Model 1 (M1) was an autoregressive model with no cross-lagged effects, also known as a
baseline or stability model. This model assumes that the predictor of the variable at Time 1 (T1)
is the same variable at Time 2 (T2) and demonstrates temporal stability of the variables over
time. All three autoregressive paths were statistically significant. The GI health construct was
stable across the two time points (β= .822, SE= .029, p < .001). Psychological distress (β = .875,
SE = .024, p < .001) and disability (β = .856, SE = .027, p < .001) exhibited significant stability.

Model 2: Cross-Lagged Model
Model 2 (M2) was a cross-lagged model extending M1 by adding cross-lagged paths
from GI health at T1 to psychological distress at T2, psychological distress at T1 to disability at
T2, and GI health at T1 to disability at T2. The autoregressive paths remained significant: GI
health: (β = .808, SE = .033, p < .001), psychological distress (β= .791, SE = .071, p < .001), and
disability (β= .660, SE = .06, p < .001). One significant cross-lagged path was found in Model 2:
GI health at Time 1 significantly predicted disability at Time 2 (β = .133, SE = .04, p < .01). The
two other cross-lagged paths were non-significant. GI health at Time 1 did not predict
psychological distress at Time 2 (β = .073, SE = .052, p = .166). Psychological distress at Time 1
did not predict disability at Time 2 (β = .085, SE = .056, p = .125). Biological sex was not
significant in any paths in Model 2 (p >.05).
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Model 3: Reverse Cross-Lagged Model
Model 3 (M3) was a reverse cross-lagged model where reverse cross-lagged paths were
run with the autoregressive statements. Reverse cross-lagged paths were added from
psychological distress at T1 to GI health at T2 and disability at T1 to psychological distress at
T2. The path of GI health at T1 to disability at T2 remained in the model. The autoregressive
pathways remained stable and significant GI health: (β= .472, SE = .127, p < .001),
psychological distress (β= .819, SE = .031, p < .001), and disability (β = .752, SE = .034, p <
.001). Both reverse cross-lagged paths were significant: psychological distress at T1 predicted GI
health at T2 (β = .221, SE = .082, p < .01) and disability at T1 predicted psychological distress at
T2 (β = .095, SE = .026, p < .001). Lastly, the pathway between GI health at T1 to disability at
T2 remained significant (β = .132, SE = .033, p < .001). Biological sex was a significant
covariate in predicting psychological distress at T2 (p = .044) but non-significant in all other
paths.

Model 4: Reciprocal Cross-Lagged Model
Model 4 (M4) was a reciprocal cross-lagged model including all autoregressive and
cross-lagged paths from M1 to M3 (Van de Schoot et al., 2012; Vötter & Schnell, 2019). The
autoregressive pathways remained stable and significant, GI health: (β = .500, SE = .1279, p <
.001), psychological distress (β = .763, SE = .069, p < .001), and disability (β = .691, SE = .059,
p < .001). Three significant cross-lagged paths were found. Psychological distress at T1
significantly predicted GI health at T2 (β = .206, SE = .084, p < .05). GI health at T1
significantly predicted disability at T2 (β = .117, SE = .039, p < .01). Lastly, disability at T1
significantly predicted psychological distress at T2 (β = .092, SE = .027, p < .01). GI health at T1
did not significantly predict psychological distress at T2 (β = .046, SE = .049, p = .351) and
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psychological distress at T1 did not predict disability at T2 (β = .065, SE = .056, p = .242.
Biological sex was not significant in any path in Model 4 (p > .05).
Table 24 shows the fit indices for Models 1-4. Table 25 shows an overview of the
standardized stability and cross-lagged coefficients. Figure 2 illustrates the standardized
coefficients of all significant paths.
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Table 24: Fit Indices for CLPM 1–4 with Latent Variables: Gastrointestinal Health,
Psychological distress, and Disability
Model

χ2

df

p

RMSEA

SRMR

CFI

TLI

Model 1

1886.725

469

.0000

.059

.098

.938

.930

Model 2

1857.398

464

.0000

.059

.090

.939

.931

Model 3

1839.593

463

.0000

.059

.089

.940

.931

Model 4

1837.007

461

.0000

.059

.089

.940

.931
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Table 25: Overview of the Standardized Stability and Cross-Lagged Coefficients
Model
1

2

3

4

Autoregressive path
GHT1
GIHT2

β
.822***

PSYT1

PSYT2

.875***

DIST1

DIST2

.856***

Cross-lagged path

β

PSYT2

.073

GHT1

GHT2

.808***

GHT1

PSYT1

PSYT2

.791***

PSYT1

DIST2

.085

DIST1

DIST2

.660***

GHT1

DIST2

.133**

GHT1

GHT2

.472***

PSYT1

GHT2

.221**

PSYT1

PSYT2

.819***

DIST1

PSYT2

.095***

DIST1

DIST2

.752***

GHT1

DIST2

.132***

GHT1

GHT2

.500***

GHT1

PSYT2

.046

PSYT1

PSYT2

.763***

PSYT1

GHT2

.206*

DIST1

DIST2

.691***

PSYT1

DIST2

.065

DIST1

PSYT2

.092**

GHT1

DIST2

.117**

GH = GI health, PSY = psychological distress, and DIS = disability; T1 = Time 1 and T2 = Time 2. Standardized coefficients (β) of all
significant paths.
*p < .05; ** p < .01; ***p < .001

GI health
Time 1

Psychological
distress
Time 1

= .500

GI health
Time 2

Disability
Time 1

= .763

Psychological
distress
Time 2

= .691

Disability
Time 2

Figure 2: Final Cross-Lagged Panel Model Results
Note. Two-wave cross-lagged panel model between GI health, psychological distress, and disability (Model 4). This figure includes
standardized coefficients (β) of all significant paths of Model 4 (continuous lines). Gray dashed lines represent the non-significant
paths of Model 4.
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CHAPTER SEVEN: DISCUSSION
This is the first study of its kind to investigate temporal relationships between latent
constructs of gastrointestinal health, psychological distress, and disability in a large sample of
emerging adults. This study had several strengths. First, the large sample size (N = 861) across
two time points allowed for an exploration of latent constructs using SEM methodology. This
exploration revealed construct validity for three latent constructs. These latent constructs were
GI health (with the use of six PROMI-GI symptom subscales), higher order psychological
distress (PHQ9, GAD7, PROMIS-Distress Depression, PROMIS-Distress Anxiety), and
disability (with the use of the six WHODAS domains of functioning). Measurement equivalence
results showed these three latent constructs were measured similarly at the two time points. The
results of the CLPM demonstrated autoregressive temporal stability (constructs were stable
across two time points) and predictive power (constructs showed meaningful relationships with
one another).
Establishing unidimensional latent variables is clinically meaningful. Many commonly
used measures do not reliably distinguish symptoms of anxiety and depression due to their highly
related nature. This, as previously discussed, is supported empirically (Cosco et al., 2012;
Teymoori et al., 2020; Wright et al., 2013). The results in this study show a higher order
construct of psychological distress can be created with four self-report measures (PHQ9, GAD7,
PROMIS-Distress Depression, PROMIS-Distress Anxiety). This aligns with the National
Institute of Mental Health’s (NIMH) Research Domain Criteria (RDoC) initiative to create
classification of mental disorders on dimensions. The development of a unidimensional
psychological distress construct using patient reported outcomes (PROs) is consistent with these
endeavors (Riley et al., 2011; Thomas Insel et al., 2010).

The creators of WHODAS have published the WHODAS factor structure, confirming the
six domains loading on a general disability factor and the unidimensionality of this measure
(Üstün et al., 2001; Üstün, Kostanjsek, et al., 2010). This study confirms this factor structure.
The psychometric evidence presented in this study established measurement equivalence across
time, temporal stability, and predictive power with the latent construct of disability.
The creation of a GI health construct was guided by a previous study conducted by the
author. The previous study found preliminary evidence of a latent construct titled GI health using
the six PROMIS-GI scales (Ross et al., 2020). This previous study was limited because it used
cross-sectional data. The current study supports this previous work and extends its findings.
Measurement equivalence results showed GI health was measured similarly across time.
Additionally, the CLPM results demonstrated autoregressive temporal stability and predictive
power of GI health. These findings have theoretical and clinical implications. As identified in the
literature review, gastrointestinal symptoms of DGBI tend to fluctuate across symptoms
domains. This has limitations in clinical settings, as patients may present with one dominant
symptom and then fluctuate to another symptom the next. For example, a patient may be
diagnosed with IBS-C or IBS-D subtype but fluctuate significantly across diagnostic domains.
The creation of a latent construct of GI health may better capture the true symptom experience in
patients with DGBI.

GI Health and Psychological Distress
There is evidence for a link between psychological distress and gastrointestinal health in
this sample of emerging adults. The significant cross-lagged pathway from psychological distress
at T1 to GI health at T2 indicated higher levels of psychological distress at Time 1 predicted
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higher GI symptom experience at Time 2 (controlling for biological sex). The cross-lagged effect
lends some preliminary evidence gastrointestinal symptoms may be a consequence of
psychological distress in emerging adults. The findings highlighted the predictor power of
psychological distress on gastrointestinal health across time. This significant cross-lagged path
supports the inference of temporal precedence and causality, as higher reported psychological
distress led to higher GI health. However, the reciprocal pathway hypothesis of GI health at
Time 1 predicting psychological distress at Time 2 was not supported. The data did not show a
significant cross-lagged path from GI health at Time 1 to psychological distress at Time 2.
Consequently, it appears in this sample, it can be inferred psychological distress preceded GI
health over time. Previous research has highlighted the strong association between psychological
distress and GI symptomatology for DGBI. However, these studies have limitations as they
utilize a cross-sectional design. Subsequently, previous work likely has not adequately controlled
(statistically) for prior distress when predicting future distress from GI symptoms. The advantage
of this study is it can make stronger causal inferences than a traditional cross-sectional design
that has been previously used to examine these relationships in DGBI (Banerjee et al., 2017;
Midenfjord et al., 2019; Patel et al., 2015; Qin et al., 2014; Simon et al., 1996; Spiegel et al.,
2008).

Psychological Distress and Disability
A significant cross-lagged pathway from disability at Time 1 to psychological distress at
Time 2 was found. This indicated higher levels of self-reported disability predicted greater
psychological distress at Time 2 among the sample. There was a pattern of significant (disability
at Time 1 to psychological distress at Time 2) vs. non-significant (psychological distress at Time
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1 to disability at Time 2) cross-lagged pathways. This significant cross-lagged path supports the
inference of temporal precedence and causality, as higher reported disability symptoms led to
higher psychological distress. Findings highlight the predictive power of disability on
psychological distress across time. It appears that in the sample, disability preceded
psychological distress over time. There was no evidence of bidirectionality and reciprocal
causality between psychological distress and disability.

GI Health and Disability
In support of initial hypotheses, GI health at Time 1 predicted disability at Time 2. The
significant cross-lagged pathway from GI health at Time 1 to disability at Time 2 indicated
higher self-reported GI symptoms at Time 1 predicted higher levels of disability at Time 2
among this sample of emerging adults. This significant cross-lagged path supports the inference
of temporal precedence and causality, as higher reported gastrointestinal symptoms led to higher
disability.

Biological Sex Differences
Descriptive analyses (independent sample t-tests) suggested biological sex differences in
several of our measures. However, Cohen’s d effect size computations indicated many of these
differences were small to medium in nature. The final CLPM results showed biological sex was
not a significant covariate in any paths of interest. Therefore, it can be concluded results
presented here adequately controlled for the variance associated with biological sex. A future
study could test for measurement equivalence across biological sex. This type of analysis would
determine if males and females are interpreting the measures similarly.
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Of potential interest could be overlap of female’s menstrual pain with self-reported GI
symptom experience. A recent study conducted in the Health Psychology Lab found no
significant multivariate differences in GI symptoms using the PROMIS-GI scales across three
phases of the menstrual cycle. The study investigated three groups of emerging adult females (N
= 531) during the Menstrual, Luteal, and Follicular phase of their menstrual cycle. No significant
multivariate differences were found in the PROMIS-GI scales across the three groups, indicating
the PROMIS-GI scales do not discriminate between phases of the menstrual cycle (Anbukkarasu,
Cassisi, and Zaman, 2021).

Limitations
The choice of time lag period in this study has limitations. One of the fundamental
choices for using CLPM is when to measure research participants and choice of the time lag.
These relationships may exist and play out across varying time periods. A future study may need
to consider modulating time lags to assess for this. For example, the relationship between
impairment in functioning and distress may play out across several weeks whereas GI symptoms
may need to be captured at the momentary and/or daily level. Additionally, this study used a
two-wave measurement. A study design with more frequent assessment over time may provide
even better information as to best timing and targets for intervention. The present study was
limited to the recall period described by each measure used. An extension of the current study
could employ the use of ecological momentary assessment (EMA) that would involve repeated
measures of symptoms in a participant’s real time. A study with more frequent assessment
overtime would support an investigation of between and within-person effects. This potential
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study could employ a random-intercept cross-lagged panel model methodology or latent growth
curve modeling. These procedures require a minimum of three waves of measurement.
Relying on self-report measures is necessary for investigating emotional states. However,
utilizing self-report measures does raise potential issues. Limitations include relying on a
participant’s recall bias, level of self-awareness, and insight. Despite these potential limitations
in utilizing self-report measures, relying on self-report is essential in research studies such as this
one. Patient-reported outcomes (PROs) quantify how a patient perceives many domains in their
life and are extensively used to determine an intervention’s success. An advantage to the selfreport measures used in this study are they are commonly used in healthcare settings. As such,
future studies could replicate these findings as the PROs used in this study are easily accessible
and freely available.
Another limitation of the present study is the sample. Data was collected from a sample
representative of the diversity at the university which did not include a clinical sample. Despite
this, the emerging adult sample presented with a range of gastrointestinal, anxiety, depressive,
and disability levels. The advantage of a non-clinical sample is it promoted an investigation of
theory-based questions (biopsychosocial and gut-brain axis model). However, results may not
generalize to other subgroups of an adult population. Additionally, emerging adults may be
experiencing additional stressors that this study did not account for. A future study could
investigate the effect of trait anxiety (Söderquist et al., 2020) and/or external stressors (Saleh et
al., 2017) in emerging adults. Future research with a wider range of adults as well as symptom
presentations would allow for a greater understanding of these variables.
One of the strengths of this study was the creation of latent variables using symptom
subscales (PROMIS-GI, GAD7, PHQ9, PROMIS-Distress Depression, PROMIS-Distress
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Anxiety, and the WHODAS). Findings show great promise in the psychometric and predictive
power of grouping these scales into latent variables. However, the grouping of symptom
measures in this way does forgo an analysis of symptom classes and severity groupings. An
extension of this study could utilize latent class analysis (LCA) to identify different symptom
classes for these latent constructs.
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CHAPTER EIGHT: CONCLUSIONS
The aim of this study was to establish the relationship between gastrointestinal health,
psychological distress, and disability across two time points in an emerging adult sample.
Findings indicated there was a significant cross-lagged pathway between psychological distress
at Time 1 to GI health at Time 2. This indicated gastrointestinal symptoms were a consequence
of psychological distress in the sample. A significant cross-lagged pathway between
psychological distress and disability was found, demonstrating higher levels of self-reported
disability predicted greater psychological distress at Time 2. Lastly, results indicated a
significant cross-lagged pathway from GI health to disability. This suggested higher self-reported
GI symptoms at Time 1 predicted higher levels of disability at Time 2.
The absence of significant reciprocal pathways inferred a directional pathway between
the brain and the gut rather than a bidirectional pathway in this sample. This signaling seems to
be stronger from the brain to the gut compared to the gut to the brain in emerging adults. These
findings offer only partial support for the GBA model. Alternatively, this study implies a more
appropriate label for the emerging adult sample may be “BGA” (brain-gut axis). These findings
could suggest a traditional psychosomatic perspective rather than supporting the bidirectionality
postulated by the GBA. The data in this study showed psychological distress was an antecedent
of gastrointestinal health rather than a showing a reciprocal relationship. This study is consistent
with previous research findings which have conceptualized IBS-like symptoms as driven by the
brain and as a stress-sensitive disorder (Qin et al., 2014). However, previous studies have not
controlled for existing distress as this current study did. Gastrointestinal symptoms have emerged
as one of the most dominant somatic symptom clusters associated with distress (Simon et al.,
1996; Spiegel et al., 2008). Emerging adults are particularly vulnerable to stress and other
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psychosocial variables. Higher psychological distress can lead to an increased stress-response,
inflammation, and arousal of the autonomic nervous system (Koloski et al., 2016; Lucas, 2018;
Mayer et al., 2015; Won & Kim, 2016). These physiological mechanisms of action have the
potential of leading to higher self-reported gastrointestinal symptoms. The significant finding of
GI health leading to increased disability over time indicated GI symptoms also accompany
functional limitations. Overall, findings highlight the role of psychological distress as a strong
contributing factor to GI symptom experience as well as overall functioning.

Clinical Implications
A focus on integrative treatment guided by the biopsychosocial model is essential for
individuals facing significant psychological distress and gastrointestinal difficulties. There is an
imperative to offer evidence-based, brain-gut psychotherapies to individuals with DGBI.
Currently, there is only 219 registered GI behavioral health providers (and only 7 in Florida),
with even fewer being licensed clinical psychologists. The Rome Foundation GastroPsych
Section has developed an initiative to expand education to providers. The temporal order of the
latent constructs found in this study suggests a direction for psychological assessment and
treatment in emerging adults. These study’s findings propose inquiry regarding GI functioning as
well as providing appropriate psychoeducation about the gut-brain connection may need to be
included as standard of care in student health services. It would not be a significant burden on
typical clinical care for a clinician to include a GI assessment measure, such as the PROMIS-GI,
to capture the overall GI functioning of their patients. Brain-gut psychotherapy treatment
options for DGBI with the strongest evidence base include mindfulness-based therapies,
cognitive behavioral therapy (including Acceptance and Commitment Therapy), and hypnosis
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(Ballou & Keefer, 2017; Gaylord et al., 2011; Naliboff et al., 2020). Psychodynamic and
interpersonal therapies have also been tested but have a weaker evidential base. Additional
psychological treatment components may include psychoeducation and exposure-based elements
(Boersma et al., 2016; Craske et al., 2011). Exposure-based therapies incorporate interoceptive
exposure to visceral sensations or target avoidance for those fearful of having a bowel movement
in a public restroom or while going about their daily activities (Boersma et al., 2016; Craske et
al., 2011). Providing a strong and compelling rationale for treatment would involve appropriate
psychoeducation about the gut-brain connection. This may help normalize an individual’s GI
experience, decrease embarrassment and stigmatization. It is recommended a clinician discuss
the interconnected network between the brain and gut to their patients and explain this system
can become dysregulated by chronic stress. A clinician could frame GI symptoms are a
burdensome and common occurrence for a large portion of the population; even those that do not
carry a formal GI disorder diagnosis. Anecdotally, most healthy individuals often experience
abdominal discomfort and changes in their bowels when they experience psychological distress.
Notably, long-term psychological distress has the potential of changing the homeostasis of the
gastrointestinal system (Chong et al., 2019; Zhou & Verne, 2011; Zhuang et al., 2017). Taken
together, brain-gut psychotherapies are an efficacious treatment option for patients with DGBI.
This study offers an empirical explanation for the interplay of self-reported
gastrointestinal symptoms, psychological distress, and disability across two points in time in
emerging adults. Results suggested self-reported GI symptoms seem to be a consequence of
psychological distress in this sample. Findings also indicated GI symptoms accompany
interference in functioning over time. These findings highlight the importance of
psychogastroenterology as an emerging field in clinical health psychology (van Tilburg, 2020).
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